≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of base of tongue, including Hilmo

Endpoint Browser PheWeb

C3_BASEOFTONGUE_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C01&
  • Hospital discharge: ICD-9 — 1410A
  • Hospital discharge: ICD-8 — 1410
  • Cause of death: ICD-10 — C01&
  • Cause of death: ICD-9 — 1410A
  • Cause of death: ICD-8 — 1410
  • Cancer registry: Topography ICD-O-3 — C01
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

322

4. Check minimum number of events

None

322

5. Include endpoints

None

322

6. Filter based on genotype QC (FinnGen only)

311

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 311 87 224
Unadjusted period prevalence (%) 0.08 0.03 0.10
Median age at first event (years) 63.50 62.87 63.74

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
322
Matched controls
3220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
307.7
264
*
130
Kela drug reimbursment
Malignant tumour
+∞
263.0
215
*
UJC01
NOMESCO Finland
Scopy of lower throat
151.4
219.7
110
11
A03FA01
ATC
metoclopramide; systemic, rectal
25.7
200.5
190
171
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
454.8
198.3
180
9
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
86.1
194.3
105
18
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
162.7
142
*
WF002
NOMESCO Finland
Radical radiotherapy
866.5
162.2
146
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
398.3
161.5
150
7
A04AA01
ATC
ondansetron; systemic, rectal
41.4
138.7
88
29
R4190
NOMESCO Finland
Nutritional therapy
39.3
137.9
89
31
GBB00
NOMESCO Finland
Tracheostomy
71.6
123.4
68
12
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
59.4
122.3
70
15
N02AA05
ATC
oxycodone; systemic
12.1
114.9
171
276
EP1AE
NOMESCO Finland
Neck ultrasound examination
21.8
112.3
92
58
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
100.4
91
*
H02AB02
ATC
dexamethasone; systemic
148.7
92.9
95
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
28.8
92.5
65
28
XX3DW
NOMESCO Finland
Time consuming IT work
16.2
90.2
86
71
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
20.2
88.3
73
46
WZC00
NOMESCO Finland
Treatment plan or consultation
8.5
81.9
209
578
EBA15
NOMESCO Finland
Extraction of multiple teeth
14.4
71.4
71
62
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
65.9
61
*
A04AA02
ATC
granisetron; systemic, transdermal
761.2
65.3
62
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
254.8
62.5
62
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
715.9
61.9
59
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
59.2
55
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
58.1
54
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
58.1
54
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
93.5
56.3
61
8
Z51.5
ICD-10 Finland
Palliative care
13.1
55.3
57
52
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
54.8
51
*
EJB20
NOMESCO Finland
Excision of tumor or other lesion of base of tongue
+∞
51.5
48
*
A07AA02
ATC
nystatin; oral
10.4
49.9
61
71
R13
ICD-10 Finland
Dysphagia
7.9
49.3
79
128
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
11.6
47.6
53
54
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
517.4
46.5
45
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
75.3
45.7
51
8
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.9
44.7
70
110
WX408
NOMESCO Finland
General anesthesy, balanced
5.0
44.5
143
440
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
477.4
43.2
42
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.8
43.1
196
785
ZX090
NOMESCO Finland
Other technic of radiotherapy
247.2
43.0
43
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
130.3
43.0
45
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
41.6
39
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
16.8
41.4
36
24
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.5
41.2
103
255
ENA10
NOMESCO Finland
Biopsy of pharynx
425.4
38.9
38
*
R4130
NOMESCO Finland
Speech therapy
12.9
38.5
39
34
WX402
NOMESCO Finland
General anaesthesia
4.8
38.4
122
366
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.5
38.0
72
137
A04AD12
ATC
aprepitant; systemic
+∞
35.0
33
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
195.6
34.5
35
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
34.0
32
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.0
33.1
194
885
EMB10
NOMESCO Finland
Tonsillectomy
10.6
33.0
38
40
A06AD11
ATC
lactulose; oral
4.6
32.0
96
271
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.8
31.8
66
136
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
31.8
30
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
31.8
30
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
31.8
30
*
WZC30
NOMESCO Finland
Teaching
4.7
31.5
90
244
SCA02
NOMESCO Finland
Preventive oral health care
6.5
30.4
55
99
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.5
29.8
46
70
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
319.3
29.3
29
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
319.3
29.3
29
*
SBB10
NOMESCO Finland
Dental impressions
7.2
29.1
47
75
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.2
28.4
54
102
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.2
28.2
40
55
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
27.5
26
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
27.5
26
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
105.9
27.1
29
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
56.9
26.7
31
6
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
26.4
25
*
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
146.8
26.0
27
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.6
25.6
72
191
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.9
25.6
37
52
8085/3-C01.9
ICD-O-3
Squamous cell carcinoma, HPV positive of base of tongue, NOS
+∞
25.3
24
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.3
24
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
25.3
24
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
270.1
25.0
25
*
EBA10
NOMESCO Finland
Operative extraction of tooth
4.8
24.6
64
159
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
7.6
23.4
35
51
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
23.2
22
*
H03AA01
ATC
levothyroxine sodium; systemic
3.6
22.8
99
355
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
22.1
21
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
235.3
21.9
22
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
235.3
21.9
22
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
117.7
20.8
22
*
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
20.0
19
*
L03AA02
ATC
filgrastim; parenteral
212.5
19.8
20
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
18.9
18
*
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
18.9
18
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
8.1
18.1
25
33
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
18.0
77
270
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
+∞
17.9
17
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
17.9
17
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
17.9
17
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
17.9
17
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
190.0
17.7
18
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.8
17.5
130
624
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
37.3
16.9
21
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
16.8
16
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
95.1
16.7
18
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
29.4
16.7
22
8
K05.31
ICD-10 Finland
Periodontitis pronounced
3.4
16.5
69
238
116
Kela drug reimbursment
Prostate cancer
+∞
15.8
15
*
L03AA13
ATC
pegfilgrastim; parenteral
167.8
15.6
16
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
15.6
45
120
JN4BD
NOMESCO Finland
Extensive body CT
5.1
15.3
34
73
JN4AD
NOMESCO Finland
Body CT examination
4.3
15.2
42
108
SAA04
NOMESCO Finland
Special examination of mouth
5.3
15.1
32
66
R4110
NOMESCO Finland
Physiotherapy
2.7
15.1
112
531
WW500
NOMESCO Finland
Blood transfusion
12.7
14.9
26
22
ZXC96
NOMESCO Finland
Robot assisted procedure
84.0
14.7
16
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
14.7
14
*
1410A
ICD-9 Finland
Malignant neoplasm of tongue, Base of tongue
+∞
14.7
14
*
EBB10
NOMESCO Finland
Insertion of dental implant
18.6
14.0
21
12
SXC03
NOMESCO Finland
Other oral or dental procedure
25.1
14.0
19
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
13.8
88
384
EJB10
NOMESCO Finland
Excision of tumor or other lesion of apex or body of tongue
35.8
13.6
17
5
C02.4
ICD-10 Finland
Malignant neoplasm: Lingual tonsil
+∞
13.6
13
*
SPA20
NOMESCO Finland
Selection and insertion of implant abutment
+∞
13.6
13
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
13.6
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
13.5
184
1142
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
10.4
13.5
26
27
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
42.0
13.3
16
*
WX002
NOMESCO Finland
Sedation and analgesia
2.7
13.0
84
367
ED1AA
NOMESCO Finland
Mandibular X-ray examination
52.2
13.0
15
*
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
3.9
12.9
40
112
J02AC01
ATC
fluconazole; systemic
2.5
12.8
118
613
C09.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tonsil
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
C09.0
ICD-10 Finland
Malignant neoplasm: Tonsillar fossa
+∞
12.6
12
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
27.9
12.2
16
6
SCA03
NOMESCO Finland
Preventive oral health care, extensive
5.1
12.1
26
54
Z3226
NOMESCO Finland
Physiotherapist
2.8
12.0
73
309
WX707
NOMESCO Finland
Fiberoscopic intubation
67.5
11.7
13
*
A02BC05
ATC
esomeprazole; systemic
2.3
11.7
158
960
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.3
11.7
24
48
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
11.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
11.5
11
*
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
+∞
11.5
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.5
11
*
R07.0
ICD-10 Finland
Pain in throat
4.1
11.5
33
87
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
13.4
11.3
19
15
WX110
NOMESCO Finland
Infiltration anesthesia
2.4
11.2
237
1720
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.0
11.1
20
35
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
29.2
10.8
14
5
B01AB10
ATC
tinzaparin; parenteral
3.5
10.7
40
127
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
62.1
10.7
12
*
K08.3
ICD-10 Finland
Retained dental root
3.2
10.6
45
155
EDW99
NOMESCO Finland
Other operation on mandible
113.6
10.5
11
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
10.5
10
*
C10.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of oropharynx
+∞
10.5
10
*
ZXE00
NOMESCO Finland
One hour or less
2.2
10.4
130
755
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
10.4
123
699
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.1
10.4
19
18
ZXB10
NOMESCO Finland
Medial
33.7
10.4
13
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
33.7
10.4
13
*
GD1AD
NOMESCO Finland
Thorax CT examination
3.9
10.4
32
89
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
19.6
10.4
15
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
10.0
114
636
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
41.4
10.0
12
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.8
9.9
23
51
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.0
9.9
19
20
Z2221
NOMESCO Finland
Medical doctor
2.3
9.9
93
479
SXA10
NOMESCO Finland
Oral mucosal sampling
20.8
9.9
14
7
R21
ICPC
Throat symptom/complaint
2.6
9.8
65
285
ZX120
NOMESCO Finland
Intravenous
3.6
9.7
33
98
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.0
9.7
48
180
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
56.7
9.7
11
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
9.4
9
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.4
9
*
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
+∞
9.4
9
*
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
9.4
9
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
9.4
9
*
8070/3-C09.9
ICD-O-3
Squamous cell carcinoma, NOS, of tonsil, NOS
+∞
9.4
9
*
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
9.4
9
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
+∞
9.4
9
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
7.7
9.4
21
29
K05.30
ICD-10 Finland
Periodontitis complex
2.5
9.4
66
298
ECA20
NOMESCO Finland
Biopsy of gingiva
24.8
9.0
12
5
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
9.0
126
758
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
8.8
50
202
UJC02
NOMESCO Finland
Rigid oesophagoscopy
14.6
8.8
14
10
L02AE02
ATC
leuprorelin; implant, parenteral
51.4
8.7
10
*
ECB20
NOMESCO Finland
Oral alveoplasty
16.9
8.6
13
8
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
92.4
8.5
9
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
92.4
8.5
9
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
13.2
8.4
14
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
8.4
79
404
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
K14.9
ICD-10 Finland
Disease of tongue, unspecified
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
8.4
8
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
8.4
8
*
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
+∞
8.4
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
8.4
8
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
8.4
8
*
UDQ22
NOMESCO Finland
Microlaryngoscopy
12.1
8.2
14
12
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
22.7
8.1
11
5
UJC12
NOMESCO Finland
Flexible oesophagoscopy
22.7
8.1
11
5
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
22.7
8.1
11
5
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
3.9
8.1
24
65
SDA03
NOMESCO Finland
Periodontal treatment
2.0
8.1
133
841
Z2446
NOMESCO Finland
Social worker
3.6
8.0
27
80
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
7.9
21
52
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.8
7.9
16
19
EBA00
NOMESCO Finland
Extraction of tooth
2.0
7.9
130
821
SXC05
NOMESCO Finland
Other oral or dental procedure
3.6
7.8
26
76
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
15.5
7.8
12
8
QA7S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in jaw or lips
46.1
7.7
9
*
K14.61
ICD-10 Finland
Glossodynia
18.9
7.7
11
6
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
25.7
7.6
10
*
DQA10
NOMESCO Finland
Biopsy of larynx
25.7
7.6
10
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.6
7.6
46
192
D10.7
ICD-10 Finland
Benign neoplasm: Hypopharynx
81.9
7.4
8
*
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
81.9
7.4
8
*
K12.10
ICD-10 Finland
Stomatitis NOS
81.9
7.4
8
*
JN6AD
NOMESCO Finland
CT of torso and neck
13.8
7.4
12
9
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
7.4
46
194
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
7.3
40
158
SDA02
NOMESCO Finland
Periodontal treatment, brief
2.0
7.3
116
718
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.9
7.3
22
60
C10.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of oropharynx
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C13.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of hypopharynx
+∞
7.3
7
*
JN5AP
NOMESCO Finland
Total body PET (1 picture)
+∞
7.3
7
*
9680/3-C01.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS
+∞
7.3
7
*
C10.0
ICD-10 Finland
Malignant neoplasm: Vallecula
+∞
7.3
7
*
ENB20
NOMESCO Finland
Pharyngectomy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8086/3-C01.9
ICD-O-3
Squamous cell carcinoma, HPV negative of base of tongue, NOS
+∞
7.3
7
*
EJB60
NOMESCO Finland
Partial excision of floor of mouth
+∞
7.3
7
*
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
+∞
7.3
7
*
GBB13
NOMESCO Finland
Revision of tracheostomy
+∞
7.3
7
*
C13.9
ICD-10 Finland
Malignant neoplasm: Hypopharynx, unspecified
+∞
7.3
7
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
7.3
7
*
115
Kela drug reimbursment
Breast cancer
+∞
7.3
7
*
EJB30
NOMESCO Finland
Excision of tumor or other lesion of floor of the mouth
+∞
7.3
7
*
SBA00
NOMESCO Finland
Microbiological examinations
7.6
7.3
16
22
T05
ICPC
Feeding problem of adult
16.2
7.3
11
7
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
4.7
7.3
17
38
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
7.3
45
190
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
12.4
7.1
12
10
K02.1
ICD-10 Finland
Caries of dentine
1.9
7.1
187
1362
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.0
7.1
20
52
ZZA00
NOMESCO Finland
Split skin graft
6.6
7.0
17
27
SPD00
NOMESCO Finland
Mucosa borne complete denture
9.6
6.8
13
14
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
40.9
6.8
8
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
6.7
24
74
ECA30
NOMESCO Finland
Excision of lesion of gingiva
12.6
6.6
11
9
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
71.2
6.4
7
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
71.2
6.4
7
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
71.2
6.4
7
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
5.4
6.4
18
35
SPA51
NOMESCO Finland
Determination of bite and dental arch location, demanding
11.3
6.3
11
10
Z3231
NOMESCO Finland
Registered nurse
2.0
6.3
88
519
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
6.3
6
*
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
EMA10
NOMESCO Finland
Biopsy of tonsil
+∞
6.3
6
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
6.3
6
*
8083/3-C01.9
ICD-O-3
Basaloid squamous cell carcinoma of base of tongue, NOS
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
C01BD, ,
ICD-10 Finland
+∞
6.3
6
*
4392
FHL
Tongue and / or Mouth resection or excision
+∞
6.3
6
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
27.3
6.3
8
*
A02BC02
ATC
pantoprazole; systemic
1.9
6.2
222
1747
EB1WA, ,
NOMESCO Finland
12.8
6.1
10
8
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.4
6.1
17
33
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.2
6.1
52
254
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.8
6.0
18
49

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Otolaryngology
4 [38004449]
7.3e-01
2.2e+00
4.8e+00
1.0e+50
6.0e+00
4.8e+00
3.9e+00
cases:19.50%
controls:10.47%
cases:24.84%
controls:3.62%
cases:53.14%
controls:0.88%
cases:50.94%
controls:0.00%
cases:71.97%
controls:0.66%
cases:82.70%
controls:3.92%
cases:86.64%
controls:11.47%
62
333
256
2847
79
115
239
3065
169
28
149
3152
162
0
156
3180
226
21
88
3158
239
122
50
2990
201
316
31
2439
Tissue Pathology biopsy report
66121-5 [40768804]
4.9e-01
1.3e+00
3.9e+00
1.0e+50
4.1e+00
2.2e+00
1.6e+00
cases:10.38%
controls:6.64%
cases:7.55%
controls:2.08%
cases:9.43%
controls:0.22%
cases:23.90%
controls:0.00%
cases:14.65%
controls:0.28%
cases:16.96%
controls:2.19%
cases:26.29%
controls:6.97%
33
211
285
2969
24
66
294
3114
30
7
288
3173
76
0
242
3180
46
9
268
3170
49
68
240
3044
61
192
171
2563
Oncology Clinic/Center
261QX0200X [38004268]
4.0e+00
4.4e+00
1.0e+50
1.0e+50
1.0e+50
1.0e+50
3.8e+00
cases:10.38%
controls:0.22%
cases:12.89%
controls:0.19%
cases:10.69%
controls:0.00%
cases:61.95%
controls:0.00%
cases:6.37%
controls:0.00%
cases:5.88%
controls:0.00%
cases:11.64%
controls:0.29%
33
7
285
3173
41
6
277
3174
34
0
284
3180
197
0
121
3180
20
0
294
3179
17
0
272
3112
27
8
205
2747
Outpatient Visit
OP [9202]
1.1e-01
4.6e-01
1.7e+00
4.1e+00
2.7e+00
1.7e+00
1.3e+00
cases:74.84%
controls:72.80%
cases:63.21%
controls:52.01%
cases:41.19%
controls:10.88%
cases:27.67%
controls:0.63%
cases:59.87%
controls:9.47%
cases:86.51%
controls:55.11%
cases:94.40%
controls:82.07%
238
2315
80
865
201
1654
117
1526
131
346
187
2834
88
20
230
3160
188
301
126
2878
250
1715
39
1397
219
2261
13
494
Oral Surgery
19 [38004464]
1.5e+00
2.1e+00
1.0e+50
1.0e+50
—
4.7e+00
3.6e+00
cases:3.14%
controls:0.72%
cases:2.52%
controls:0.31%
cases:5.03%
controls:0.00%
cases:4.40%
controls:0.00%
—
—
cases:19.72%
controls:0.22%
cases:14.22%
controls:0.47%
10
23
308
3157
8
10
310
3170
16
0
302
3180
14
0
304
3180
—
57
7
232
3105
33
13
199
2742
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.6e-01
8.6e-01
2.5e+00
—
3.8e+00
1.9e+00
9.8e-01
cases:10.69%
controls:5.82%
cases:6.60%
controls:2.89%
cases:4.40%
controls:0.38%
—
—
cases:13.38%
controls:0.35%
cases:14.88%
controls:2.47%
cases:18.97%
controls:8.09%
34
185
284
2995
21
92
297
3088
14
12
304
3168
—
42
11
272
3168
43
77
246
3035
44
223
188
2532
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
2.6e-01
8.5e-01
3.6e+00
1.0e+50
4.6e+00
1.3e+00
1.2e+00
cases:11.01%
controls:8.71%
cases:5.35%
controls:2.36%
cases:6.60%
controls:0.19%
cases:4.72%
controls:0.00%
cases:17.52%
controls:0.22%
cases:7.96%
controls:2.38%
cases:20.69%
controls:7.08%
35
277
283
2903
17
75
301
3105
21
6
297
3174
15
0
303
3180
55
7
259
3172
23
74
266
3038
48
195
184
2560
Treatment plan or consultation
WZC00 [2001310885]
4.8e-01
1.1e+00
—
1.0e+50
4.9e+00
3.7e+00
1.9e+00
cases:7.55%
controls:4.81%
cases:4.09%
controls:1.45%
—
—
cases:3.77%
controls:0.00%
cases:22.93%
controls:0.22%
cases:28.72%
controls:1.00%
cases:27.16%
controls:5.08%
24
153
294
3027
13
46
305
3134
—
12
0
306
3180
72
7
242
3172
83
31
206
3081
63
140
169
2615
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.9e-01
5.2e-01
2.7e+00
1.0e+50
4.4e+00
2.3e+00
1.0e+00
cases:9.12%
controls:5.79%
cases:5.03%
controls:3.05%
cases:4.40%
controls:0.31%
cases:2.52%
controls:0.00%
cases:11.46%
controls:0.16%
cases:18.34%
controls:2.12%
cases:16.81%
controls:6.86%
29
184
289
2996
16
97
302
3083
14
10
304
3170
8
0
310
3180
36
5
278
3174
53
66
236
3046
39
189
193
2566
Extended examination of mouth
SAA03 [2001310276]
-1.6e-01
1.1e+00
—
—
4.8e+00
3.1e+00
2.2e+00
cases:7.23%
controls:8.40%
cases:3.77%
controls:1.35%
—
—
—
—
cases:18.47%
controls:0.19%
cases:23.18%
controls:1.32%
cases:30.17%
controls:4.43%
23
267
295
2913
12
43
306
3137
—
—
58
6
256
3173
67
41
222
3071
70
122
162
2633
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.1e-01
1.0e+00
—
—
4.8e+00
3.9e+00
1.4e+00
cases:4.09%
controls:2.48%
cases:3.14%
controls:1.16%
—
—
—
—
cases:18.47%
controls:0.19%
cases:38.75%
controls:1.29%
cases:17.24%
controls:4.86%
13
79
305
3101
10
37
308
3143
—
—
58
6
256
3173
112
40
177
3072
40
134
192
2621
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-1.8e-01
4.7e-01
1.7e+00
3.5e+00
2.8e+00
1.5e+00
1.6e-01
cases:33.02%
controls:37.20%
cases:31.76%
controls:22.45%
cases:18.87%
controls:4.25%
cases:5.03%
controls:0.16%
cases:37.58%
controls:3.37%
cases:57.79%
controls:23.17%
cases:52.16%
controls:48.28%
105
1183
213
1997
101
714
217
2466
60
135
258
3045
16
5
302
3175
118
107
196
3072
167
721
122
2391
121
1330
111
1425
Outpatient Hospital
22 [8756]
1.8e-01
5.8e-01
2.5e+00
—
4.3e+00
2.2e+00
9.9e-01
cases:26.10%
controls:22.74%
cases:10.69%
controls:6.29%
cases:9.12%
controls:0.82%
—
—
cases:30.57%
controls:0.60%
cases:31.14%
controls:4.66%
cases:24.57%
controls:10.82%
83
723
235
2457
34
200
284
2980
29
26
289
3154
—
96
19
218
3160
90
145
199
2967
57
298
175
2457
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
1.8e-01
2.2e-01
3.3e+00
1.0e+50
3.9e+00
1.9e+00
7.7e-01
cases:9.43%
controls:7.99%
cases:5.97%
controls:4.87%
cases:7.86%
controls:0.31%
cases:2.83%
controls:0.00%
cases:14.33%
controls:0.35%
cases:18.69%
controls:3.34%
cases:22.41%
controls:11.76%
30
254
288
2926
19
155
299
3025
25
10
293
3170
9
0
309
3180
45
11
269
3168
54
104
235
3008
52
324
180
2431
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2.5e-01
1.6e-01
2.0e+00
—
3.8e+00
2.8e+00
8.4e-01
cases:7.23%
controls:5.72%
cases:3.14%
controls:2.70%
cases:2.52%
controls:0.35%
—
—
cases:11.46%
controls:0.28%
cases:29.07%
controls:2.35%
cases:18.97%
controls:9.18%
23
182
295
2998
10
86
308
3094
8
11
310
3169
—
36
9
278
3170
84
73
205
3039
44
253
188
2502
Inpatient Visit
IP [9201]
4.6e-01
5.3e-01
2.8e+00
—
3.5e+00
2.0e+00
9.0e-01
cases:8.18%
controls:5.31%
cases:5.66%
controls:3.40%
cases:4.09%
controls:0.25%
—
—
cases:10.19%
controls:0.35%
cases:18.34%
controls:2.83%
cases:22.84%
controls:10.74%
26
169
292
3011
18
108
300
3072
13
8
305
3172
—
32
11
282
3168
53
88
236
3024
53
296
179
2459
Dentistry
C5 [903277]
8.8e-01
2.1e+00
—
—
—
4.4e+00
2.8e+00
cases:5.35%
controls:2.30%
cases:5.35%
controls:0.69%
—
—
—
—
—
—
cases:36.68%
controls:0.74%
cases:25.86%
controls:2.07%
17
73
301
3107
17
22
301
3158
—
—
—
106
23
183
3089
60
57
172
2698
Laboratory Visit
OMOP4822461 [32036]
1.3e-03
2.9e-01
1.7e+00
4.6e+00
2.1e+00
6.3e-01
1.5e-01
cases:53.77%
controls:53.74%
cases:56.29%
controls:49.06%
cases:49.06%
controls:14.43%
cases:40.57%
controls:0.66%
cases:56.69%
controls:14.16%
cases:66.44%
controls:51.35%
cases:74.57%
controls:71.62%
171
1709
147
1471
179
1560
139
1620
156
459
162
2721
129
21
189
3159
178
450
136
2729
192
1598
97
1514
173
1973
59
782
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-1.0e-02
3.7e-02
1.9e+00
3.3e+00
2.7e+00
9.4e-01
0.0e+00
cases:45.28%
controls:45.53%
cases:39.31%
controls:38.43%
cases:34.91%
controls:7.11%
cases:8.81%
controls:0.35%
cases:51.27%
controls:6.76%
cases:63.32%
controls:40.20%
cases:65.52%
controls:65.52%
144
1448
174
1732
125
1222
193
1958
111
226
207
2954
28
11
290
3169
161
215
153
2964
183
1251
106
1861
152
1805
80
950
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
1.2e-01
1.5e-01
1.9e+00
2.9e+00
2.7e+00
1.2e+00
2.4e-01
cases:30.82%
controls:28.40%
cases:29.25%
controls:26.23%
cases:25.79%
controls:4.84%
cases:5.66%
controls:0.31%
cases:41.72%
controls:4.53%
cases:57.09%
controls:28.18%
cases:57.76%
controls:51.72%
98
903
220
2277
93
834
225
2346
82
154
236
3026
18
10
300
3170
131
144
183
3035
165
877
124
2235
134
1425
98
1330
Upper gastrointestinal surgery
106 [44777669]
5.1e-01
8.3e-01
2.0e+00
—
2.5e+00
2.3e+00
9.4e-01
cases:14.47%
controls:9.18%
cases:7.23%
controls:3.30%
cases:2.83%
controls:0.38%
—
—
cases:5.73%
controls:0.47%
cases:23.53%
controls:3.05%
cases:21.55%
controls:9.73%
46
292
272
2888
23
105
295
3075
9
12
309
3168
—
18
15
296
3164
68
95
221
3017
50
268
182
2487
Scheduled procedure
ZXD10 [2001311387]
4.4e-01
1.3e+00
2.9e+00
1.0e+50
—
2.8e+00
1.5e+00
cases:10.06%
controls:6.73%
cases:4.09%
controls:1.19%
cases:2.83%
controls:0.16%
cases:5.35%
controls:0.00%
—
—
cases:12.46%
controls:0.87%
cases:9.91%
controls:2.36%
32
214
286
2966
13
38
305
3142
9
5
309
3175
17
0
301
3180
—
36
27
253
3085
23
65
209
2690
Inpatient Hospital
21 [8717]
4.7e-02
5.6e-01
2.2e+00
1.0e+50
3.6e+00
2.0e+00
7.2e-01
cases:28.62%
controls:27.67%
cases:13.84%
controls:8.40%
cases:9.43%
controls:1.19%
cases:12.58%
controls:0.00%
cases:31.21%
controls:1.23%
cases:37.02%
controls:7.39%
cases:26.72%
controls:15.03%
91
880
227
2300
44
267
274
2913
30
38
288
3142
40
0
278
3180
98
39
216
3140
107
230
182
2882
62
414
170
2341
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
7.7e-03
-9.1e-02
1.6e+00
3.2e+00
2.6e+00
1.0e+00
-1.2e-02
cases:42.14%
controls:41.95%
cases:32.08%
controls:34.09%
cases:23.27%
controls:5.72%
cases:7.86%
controls:0.35%
cases:43.31%
controls:5.35%
cases:59.86%
controls:35.03%
cases:59.48%
controls:59.78%
134
1334
184
1846
102
1084
216
2096
74
182
244
2998
25
11
293
3169
136
170
178
3009
173
1090
116
2022
138
1647
94
1108
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
2.5e-01
8.4e-01
1.4e+00
—
3.0e+00
2.4e+00
7.0e-01
cases:15.41%
controls:12.42%
cases:16.98%
controls:8.08%
cases:7.23%
controls:1.86%
—
—
cases:24.84%
controls:1.54%
cases:47.75%
controls:7.94%
cases:32.76%
controls:19.49%
49
395
269
2785
54
257
264
2923
23
59
295
3121
—
78
49
236
3130
138
247
151
2865
76
537
156
2218
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.5e-02
-6.3e-02
1.6e+00
3.2e+00
2.6e+00
9.9e-01
-1.4e-02
cases:42.77%
controls:42.39%
cases:33.02%
controls:34.43%
cases:23.27%
controls:5.79%
cases:7.55%
controls:0.35%
cases:43.95%
controls:5.41%
cases:59.86%
controls:35.70%
cases:59.91%
controls:60.25%
136
1348
182
1832
105
1095
213
2085
74
184
244
2996
24
11
294
3169
138
172
176
3007
173
1111
116
2001
139
1660
93
1095
CBC panel - Blood by Automated count
58410-2 [40761511]
-1.7e-02
4.8e-02
1.7e+00
3.6e+00
2.2e+00
6.6e-01
3.1e-03
cases:40.57%
controls:40.97%
cases:30.19%
controls:29.18%
cases:20.75%
controls:4.65%
cases:7.55%
controls:0.22%
cases:29.94%
controls:4.37%
cases:42.56%
controls:27.67%
cases:51.29%
controls:51.22%
129
1303
189
1877
96
928
222
2252
66
148
252
3032
24
7
294
3173
94
139
220
3040
123
861
166
2251
119
1411
113
1344
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.8e-02
1.5e-01
1.6e+00
3.2e+00
2.5e+00
8.6e-01
-3.2e-02
cases:49.06%
controls:48.62%
cases:44.97%
controls:41.19%
cases:30.50%
controls:8.05%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.05%
cases:62.63%
controls:41.55%
cases:66.81%
controls:67.51%
156
1546
162
1634
143
1310
175
1870
97
256
221
2924
27
12
291
3168
147
224
167
2955
181
1293
108
1819
155
1860
77
895
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.8e-02
1.6e-01
1.6e+00
3.2e+00
2.5e+00
8.6e-01
-3.7e-02
cases:49.06%
controls:48.62%
cases:45.28%
controls:41.26%
cases:30.50%
controls:8.05%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.05%
cases:62.63%
controls:41.58%
cases:66.81%
controls:67.62%
156
1546
162
1634
144
1312
174
1868
97
256
221
2924
27
12
291
3168
147
224
167
2955
181
1294
108
1818
155
1863
77
892
Dysphagia
R13 [45573013]
1.1e+00
2.9e+00
—
—
—
3.2e+00
2.0e+00
cases:1.89%
controls:0.63%
cases:3.46%
controls:0.19%
—
—
—
—
—
—
cases:5.88%
controls:0.26%
cases:6.03%
controls:0.87%
6
20
312
3160
11
6
307
3174
—
—
—
17
8
272
3104
14
24
218
2731
Platelets [#/volume] in Blood
26515-7 [3007461]
1.5e-02
1.7e-01
1.6e+00
3.2e+00
2.5e+00
8.5e-01
-3.2e-02
cases:48.74%
controls:48.36%
cases:45.28%
controls:41.10%
cases:30.50%
controls:8.05%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.05%
cases:62.28%
controls:41.39%
cases:66.81%
controls:67.51%
155
1538
163
1642
144
1307
174
1873
97
256
221
2924
27
12
291
3168
147
224
167
2955
180
1288
109
1824
155
1860
77
895
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.4e-02
1.8e-01
1.6e+00
3.2e+00
2.4e+00
8.5e-01
-3.9e-02
cases:49.06%
controls:48.71%
cases:45.60%
controls:41.29%
cases:30.50%
controls:8.05%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.08%
cases:62.63%
controls:41.65%
cases:66.81%
controls:67.66%
156
1549
162
1631
145
1313
173
1867
97
256
221
2924
27
12
291
3168
147
225
167
2954
181
1296
108
1816
155
1864
77
891
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.8e-02
1.6e-01
1.6e+00
3.2e+00
2.4e+00
8.6e-01
-3.7e-02
cases:49.06%
controls:48.62%
cases:45.28%
controls:41.26%
cases:30.50%
controls:8.08%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.08%
cases:62.63%
controls:41.55%
cases:66.81%
controls:67.62%
156
1546
162
1634
144
1312
174
1868
97
257
221
2923
27
12
291
3168
147
225
167
2954
181
1293
108
1819
155
1863
77
892
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.9e-02
1.8e-01
1.6e+00
3.2e+00
2.4e+00
8.5e-01
-3.7e-02
cases:49.06%
controls:48.58%
cases:45.60%
controls:41.16%
cases:30.50%
controls:8.08%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.08%
cases:62.63%
controls:41.68%
cases:66.81%
controls:67.62%
156
1545
162
1635
145
1309
173
1871
97
257
221
2923
27
12
291
3168
147
225
167
2954
181
1297
108
1815
155
1863
77
892
MCH [Entitic mass]
28539-5 [3035941]
2.3e-02
1.7e-01
1.6e+00
3.2e+00
2.5e+00
8.6e-01
-3.4e-02
cases:49.06%
controls:48.49%
cases:45.28%
controls:41.23%
cases:30.19%
controls:8.05%
cases:8.49%
controls:0.38%
cases:46.82%
controls:7.05%
cases:62.63%
controls:41.55%
cases:66.81%
controls:67.55%
156
1542
162
1638
144
1311
174
1869
96
256
222
2924
27
12
291
3168
147
224
167
2955
181
1293
108
1819
155
1861
77
894
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.4e+00
1.3e+00
—
—
1.0e+50
4.7e+00
2.0e+00
cases:5.03%
controls:1.32%
cases:2.83%
controls:0.75%
—
—
—
—
cases:12.10%
controls:0.00%
cases:42.91%
controls:0.71%
cases:12.07%
controls:1.74%
16
42
302
3138
9
24
309
3156
—
—
38
0
276
3179
124
22
165
3090
28
48
204
2707
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.7e-01
4.1e-01
1.7e+00
2.8e+00
2.5e+00
1.0e+00
1.1e-01
cases:32.39%
controls:28.84%
cases:32.08%
controls:23.84%
cases:22.01%
controls:4.84%
cases:5.66%
controls:0.35%
cases:34.71%
controls:4.25%
cases:47.75%
controls:25.19%
cases:48.71%
controls:46.03%
103
917
215
2263
102
758
216
2422
70
154
248
3026
18
11
300
3169
109
135
205
3044
138
784
151
2328
113
1268
119
1487
Infiltration anesthesia
WX110 [2001310767]
7.0e-02
7.4e-01
1.9e+00
—
2.9e+00
1.5e+00
1.0e+00
cases:23.27%
controls:22.04%
cases:14.47%
controls:7.45%
cases:6.29%
controls:1.01%
—
—
cases:14.65%
controls:0.98%
cases:26.64%
controls:7.74%
cases:43.10%
controls:21.52%
74
701
244
2479
46
237
272
2943
20
32
298
3148
—
46
31
268
3148
77
241
212
2871
100
593
132
2162
INR in Blood by Coagulation assay
34714-6 [3032080]
-4.5e-02
2.9e-01
1.4e+00
3.0e+00
1.9e+00
1.5e+00
5.2e-01
cases:12.58%
controls:13.08%
cases:9.43%
controls:7.23%
cases:9.75%
controls:2.55%
cases:3.77%
controls:0.19%
cases:16.24%
controls:2.74%
cases:28.03%
controls:7.78%
cases:25.00%
controls:16.55%
40
416
278
2764
30
230
288
2950
31
81
287
3099
12
6
306
3174
51
87
263
3092
81
242
208
2870
58
456
174
2299
Thorax X-ray examination
GD1AA [2001303617]
1.6e-01
4.7e-01
2.2e+00
—
2.5e+00
1.9e+00
1.2e+00
cases:11.64%
controls:10.06%
cases:5.66%
controls:3.62%
cases:2.20%
controls:0.25%
—
—
cases:6.05%
controls:0.50%
cases:17.65%
controls:3.15%
cases:28.02%
controls:10.38%
37
320
281
2860
18
115
300
3065
7
8
311
3172
—
19
16
295
3163
51
98
238
3014
65
286
167
2469
Physiotherapy
R4110 [2001310233]
5.9e-01
7.1e-01
2.2e+00
—
3.3e+00
2.3e+00
6.0e-01
cases:8.49%
controls:4.91%
cases:3.77%
controls:1.89%
cases:2.52%
controls:0.28%
—
—
cases:5.73%
controls:0.22%
cases:12.80%
controls:1.51%
cases:8.19%
controls:4.65%
27
156
291
3024
12
60
306
3120
8
9
310
3171
—
18
7
296
3172
37
47
252
3065
19
128
213
2627
Flexible laryngoscopy
UDQ12 [2001301827]
1.8e+00
2.7e+00
—
1.0e+50
1.0e+50
—
3.1e+00
cases:2.52%
controls:0.41%
cases:2.20%
controls:0.16%
—
—
cases:1.89%
controls:0.00%
cases:2.87%
controls:0.00%
—
—
cases:12.50%
controls:0.65%
8
13
310
3167
7
5
311
3175
—
6
0
312
3180
9
0
305
3179
—
29
18
203
2737
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.6e-01
6.3e-01
1.6e+00
—
2.9e+00
2.2e+00
8.2e-01
cases:14.78%
controls:10.75%
cases:9.43%
controls:5.25%
cases:4.09%
controls:0.85%
—
—
cases:12.74%
controls:0.79%
cases:35.29%
controls:5.78%
cases:30.17%
controls:16.01%
47
342
271
2838
30
167
288
3013
13
27
305
3153
—
40
25
274
3154
102
180
187
2932
70
441
162
2314
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.3e-01
4.8e-01
2.1e+00
—
2.8e+00
1.9e+00
7.3e-01
cases:10.38%
controls:9.25%
cases:7.86%
controls:5.00%
cases:5.03%
controls:0.66%
—
—
cases:12.10%
controls:0.82%
cases:25.26%
controls:4.82%
cases:26.72%
controls:14.99%
33
294
285
2886
25
159
293
3021
16
21
302
3159
—
38
26
276
3153
73
150
216
2962
62
413
170
2342
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
—
-1.0e+50
—
—
—
4.7e+00
2.8e+00
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
cases:15.22%
controls:0.16%
cases:6.03%
controls:0.40%
—
0
5
318
3175
—
—
—
44
5
245
3107
14
11
218
2744
Multidisciplinary treatment meeting
WZC20 [2001310890]
—
—
—
1.0e+50
1.0e+50
4.3e+00
3.1e+00
—
—
—
—
—
—
cases:2.20%
controls:0.00%
cases:9.24%
controls:0.00%
cases:10.73%
controls:0.16%
cases:5.60%
controls:0.25%
—
—
—
7
0
311
3180
29
0
285
3179
31
5
258
3107
13
7
219
2748
cefalexin; oral
J01DB01 [21602870]
1.4e-01
8.8e-01
1.7e+00
—
2.5e+00
1.6e+00
7.3e-01
cases:28.93%
controls:26.07%
cases:17.30%
controls:7.99%
cases:4.09%
controls:0.79%
—
—
cases:8.92%
controls:0.79%
cases:30.45%
controls:7.81%
cases:38.79%
controls:23.48%
92
829
226
2351
55
254
263
2926
13
25
305
3155
—
28
25
286
3154
88
243
201
2869
90
647
142
2108
phenoxymethylpenicillin; oral
J01CE02 [21602842]
3.5e-01
9.9e-01
1.9e+00
—
3.7e+00
8.8e-01
5.0e-01
cases:16.67%
controls:12.33%
cases:7.86%
controls:3.08%
cases:2.20%
controls:0.35%
—
—
cases:8.28%
controls:0.22%
cases:9.00%
controls:3.95%
cases:16.81%
controls:10.96%
53
392
265
2788
25
98
293
3082
7
11
311
3169
—
26
7
288
3172
26
123
263
2989
39
302
193
2453
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
3.5e-01
9.9e-01
1.9e+00
—
3.7e+00
8.8e-01
5.0e-01
cases:16.67%
controls:12.33%
cases:7.86%
controls:3.08%
cases:2.20%
controls:0.35%
—
—
cases:8.28%
controls:0.22%
cases:9.00%
controls:3.95%
cases:16.81%
controls:10.96%
53
392
265
2788
25
98
293
3082
7
11
311
3169
—
26
7
288
3172
26
123
263
2989
39
302
193
2453
Nutritional therapy
R4190 [2001310243]
—
—
—
—
—
4.8e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:19.72%
controls:0.19%
cases:5.17%
controls:0.47%
—
—
—
—
—
57
6
232
3106
12
13
220
2742
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-2.2e-01
-8.7e-03
2.5e+00
—
3.1e+00
1.6e+00
3.8e-01
cases:12.26%
controls:14.78%
cases:7.86%
controls:7.92%
cases:8.18%
controls:0.75%
—
—
cases:14.01%
controls:0.75%
cases:29.07%
controls:7.36%
cases:29.74%
controls:22.43%
39
470
279
2710
25
252
293
2928
26
24
292
3156
—
44
24
270
3155
84
229
205
2883
69
618
163
2137
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-8.1e-03
2.1e-01
1.4e+00
2.9e+00
2.2e+00
5.2e-01
-1.2e-01
cases:36.79%
controls:36.98%
cases:33.65%
controls:29.06%
cases:19.81%
controls:5.63%
cases:3.77%
controls:0.22%
cases:31.21%
controls:4.72%
cases:41.18%
controls:29.31%
cases:46.12%
controls:49.18%
117
1176
201
2004
107
924
211
2256
63
179
255
3001
12
7
306
3173
98
150
216
3029
119
912
170
2200
107
1355
125
1400
Office Visit
OMOP4822458 [581477]
-5.9e-02
4.1e-01
2.6e+00
1.0e+50
—
3.2e+00
1.1e+00
cases:7.23%
controls:7.64%
cases:2.83%
controls:1.89%
cases:2.52%
controls:0.19%
cases:1.57%
controls:0.00%
—
—
cases:23.53%
controls:1.19%
cases:11.21%
controls:3.85%
23
243
295
2937
9
60
309
3120
8
6
310
3174
5
0
313
3180
—
68
37
221
3075
26
106
206
2649
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
2.5e-01
2.7e-01
2.7e+00
—
2.6e+00
1.8e+00
4.8e-01
cases:5.03%
controls:3.96%
cases:1.89%
controls:1.45%
cases:2.20%
controls:0.16%
—
—
cases:3.18%
controls:0.25%
cases:8.30%
controls:1.51%
cases:3.88%
controls:2.43%
16
126
302
3054
6
46
312
3134
7
5
311
3175
—
10
8
304
3171
24
47
265
3065
9
67
223
2688
lactulose; oral
A06AD11 [21600571]
1.2e+00
7.4e-01
—
—
3.2e+00
2.6e+00
8.4e-01
cases:5.35%
controls:1.70%
cases:1.89%
controls:0.91%
—
—
—
—
cases:4.46%
controls:0.19%
cases:12.46%
controls:1.06%
cases:6.47%
controls:2.90%
17
54
301
3126
6
29
312
3151
—
—
14
6
300
3173
36
33
253
3079
15
80
217
2675
One hour or less
ZXE00 [2001311394]
1.6e-01
9.1e-01
2.8e+00
1.0e+50
—
2.7e+00
1.4e+00
cases:8.81%
controls:7.58%
cases:3.46%
controls:1.42%
cases:3.46%
controls:0.22%
cases:6.29%
controls:0.00%
—
—
cases:12.11%
controls:0.90%
cases:10.78%
controls:2.83%
28
241
290
2939
11
45
307
3135
11
7
307
3173
20
0
298
3180
—
35
28
254
3084
25
78
207
2677
General Practice Dentistry
1223G0001X [38003675]
2.5e+00
—
—
—
1.0e+50
—
4.5e+00
cases:2.52%
controls:0.22%
—
—
—
—
—
—
cases:7.32%
controls:0.00%
—
—
cases:15.95%
controls:0.22%
8
7
310
3173
—
—
—
23
0
291
3179
—
37
6
195
2749
Cathetrisation of artery
TPH07 [2001309747]
7.7e-01
1.9e+00
—
—
—
3.4e+00
1.6e+00
cases:1.89%
controls:0.88%
cases:2.52%
controls:0.38%
—
—
—
—
—
—
cases:6.23%
controls:0.22%
cases:6.03%
controls:1.34%
6
28
312
3152
8
12
310
3168
—
—
—
18
7
271
3105
14
37
218
2718
Case Management Agency
251B00000X [38004193]
2.0e-01
1.7e-01
1.2e+00
3.3e+00
1.6e+00
7.2e-01
4.0e-01
cases:75.16%
controls:71.23%
cases:66.98%
controls:63.18%
cases:54.40%
controls:26.01%
cases:29.25%
controls:1.57%
cases:62.42%
controls:25.07%
cases:80.28%
controls:66.55%
cases:89.22%
controls:84.79%
239
2265
79
915
213
2009
105
1171
173
827
145
2353
93
50
225
3130
196
797
118
2382
232
2071
57
1041
207
2336
25
419
More than one and less than three hours
ZXE10 [2001311401]
4.4e-01
9.0e-01
3.0e+00
—
—
2.2e+00
1.4e+00
cases:8.81%
controls:5.85%
cases:2.52%
controls:1.04%
cases:3.14%
controls:0.16%
—
—
—
—
cases:7.61%
controls:0.90%
cases:9.05%
controls:2.29%
28
186
290
2994
8
33
310
3147
10
5
308
3175
—
—
22
28
267
3084
21
63
211
2692
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
5.7e-01
5.3e-01
1.7e+00
—
3.1e+00
1.9e+00
3.5e-01
cases:13.52%
controls:8.14%
cases:4.40%
controls:2.64%
cases:2.52%
controls:0.47%
—
—
cases:6.05%
controls:0.28%
cases:13.84%
controls:2.44%
cases:9.91%
controls:7.19%
43
259
275
2921
14
84
304
3096
8
15
310
3165
—
19
9
295
3170
40
76
249
3036
23
198
209
2557
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
1.2e+00
1.0e+00
—
1.0e+50
—
3.9e+00
1.4e+00
cases:4.40%
controls:1.38%
cases:2.20%
controls:0.82%
—
—
cases:1.89%
controls:0.00%
—
—
cases:22.84%
controls:0.58%
cases:8.19%
controls:2.07%
14
44
304
3136
7
26
311
3154
—
6
0
312
3180
—
66
18
223
3094
19
57
213
2698
General anesthesia, balanced
WX408 [2001310808]
5.5e-01
1.4e+00
—
1.0e+50
—
3.3e+00
1.7e+00
cases:6.92%
controls:4.12%
cases:3.77%
controls:0.91%
—
—
cases:7.23%
controls:0.00%
—
—
cases:12.80%
controls:0.51%
cases:7.33%
controls:1.38%
22
131
296
3049
12
29
306
3151
—
23
0
295
3180
—
37
16
252
3096
17
38
215
2717
Periodontitis complex
K05.30 [2000502728]
—
—
—
—
3.1e+00
2.4e+00
1.1e+00
—
—
—
—
—
—
—
—
cases:5.10%
controls:0.25%
cases:7.27%
controls:0.71%
cases:8.19%
controls:3.01%
—
—
—
—
16
8
298
3171
21
22
268
3090
19
83
213
2672
Rhinopharyngoscopy
UDH02 [2001301680]
—
—
1.0e+50
—
1.0e+50
4.1e+00
2.4e+00
—
—
—
—
cases:2.52%
controls:0.00%
—
—
cases:2.23%
controls:0.00%
cases:9.00%
controls:0.16%
cases:5.60%
controls:0.54%
—
—
8
0
310
3180
—
7
0
307
3179
26
5
263
3107
13
15
219
2740
Chronic apical periodontitis
K04.5 [45586691]
8.7e-02
8.8e-01
—
—
3.8e+00
1.9e+00
8.3e-01
cases:5.97%
controls:5.50%
cases:4.09%
controls:1.73%
—
—
—
—
cases:13.06%
controls:0.35%
cases:13.15%
controls:2.25%
cases:12.07%
controls:5.66%
19
175
299
3005
13
55
305
3125
—
—
41
11
273
3168
38
70
251
3042
28
156
204
2599
Biopsy of tongue or floor of mouth
EJA10 [2001302171]
2.3e+00
1.0e+50
1.0e+50
1.0e+50
—
1.0e+50
4.1e+00
cases:1.89%
controls:0.19%
cases:3.46%
controls:0.00%
cases:7.23%
controls:0.00%
cases:8.81%
controls:0.00%
—
—
cases:7.61%
controls:0.00%
cases:9.91%
controls:0.18%
6
6
312
3174
11
0
307
3180
23
0
295
3180
28
0
290
3180
—
22
0
267
3112
23
5
209
2750
Supplier / Service Provider
OMOP5117446 [33004]
-9.1e-01
-8.8e-01
1.5e+00
—
—
3.5e+00
2.3e+00
cases:14.15%
controls:29.12%
cases:4.72%
controls:10.66%
cases:3.77%
controls:0.88%
—
—
—
—
cases:20.42%
controls:0.77%
cases:14.22%
controls:1.63%
45
926
273
2254
15
339
303
2841
12
28
306
3152
—
—
59
24
230
3088
33
45
199
2710
oxycodone; oral, parenteral
N02AA05 [21604260]
8.3e-01
1.1e+00
—
—
—
4.6e+00
1.6e+00
cases:2.83%
controls:1.26%
cases:2.20%
controls:0.72%
—
—
—
—
—
—
cases:37.72%
controls:0.58%
cases:12.07%
controls:2.58%
9
40
309
3140
7
23
311
3157
—
—
—
109
18
180
3094
28
71
204
2684
esomeprazole; oral, parenteral
A02BC05 [21600100]
3.9e-01
8.2e-01
1.1e+00
—
2.3e+00
2.1e+00
1.1e+00
cases:12.89%
controls:9.09%
cases:9.12%
controls:4.21%
cases:2.83%
controls:1.01%
—
—
cases:9.87%
controls:1.10%
cases:26.64%
controls:4.24%
cases:19.83%
controls:7.88%
41
289
277
2891
29
134
289
3046
9
32
309
3148
—
31
35
283
3144
77
132
212
2980
46
217
186
2538
Intravenous general anesthesia
WX404 [2001310807]
6.1e-01
1.6e+00
—
—
—
2.6e+00
2.0e+00
cases:5.35%
controls:2.99%
cases:2.83%
controls:0.57%
—
—
—
—
—
—
cases:4.15%
controls:0.32%
cases:4.31%
controls:0.62%
17
95
301
3085
9
18
309
3162
—
—
—
12
10
277
3102
10
17
222
2738
codeine and paracetamol
N02AJ06 [1123647]
-4.7e-01
-2.6e-02
1.5e+00
—
2.5e+00
2.1e+00
2.7e-01
cases:11.32%
controls:16.98%
cases:6.29%
controls:6.45%
cases:4.72%
controls:1.07%
—
—
cases:10.19%
controls:0.88%
cases:35.29%
controls:6.20%
cases:21.12%
controls:16.95%
36
540
282
2640
20
205
298
2975
15
34
303
3146
—
32
28
282
3151
102
193
187
2919
49
467
183
2288
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.2e-01
8.5e-01
1.5e+00
—
1.9e+00
1.2e+00
6.6e-01
cases:12.58%
controls:10.38%
cases:15.09%
controls:7.08%
cases:6.29%
controls:1.45%
—
—
cases:7.32%
controls:1.13%
cases:19.72%
controls:6.81%
cases:27.59%
controls:16.41%
40
330
278
2850
48
225
270
2955
20
46
298
3134
—
23
36
291
3143
57
212
232
2900
64
452
168
2303
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.1e-01
8.4e-01
1.5e+00
—
1.9e+00
1.2e+00
6.5e-01
cases:12.58%
controls:10.41%
cases:15.09%
controls:7.11%
cases:6.29%
controls:1.42%
—
—
cases:7.32%
controls:1.13%
cases:19.72%
controls:6.88%
cases:27.16%
controls:16.26%
40
331
278
2849
48
226
270
2954
20
45
298
3135
—
23
36
291
3143
57
214
232
2898
63
448
169
2307
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.8e-01
7.9e-01
1.5e+00
—
1.9e+00
1.2e+00
6.5e-01
cases:12.26%
controls:10.47%
cases:14.47%
controls:7.11%
cases:6.29%
controls:1.45%
—
—
cases:7.32%
controls:1.16%
cases:19.72%
controls:6.88%
cases:27.16%
controls:16.23%
39
333
279
2847
46
226
272
2954
20
46
298
3134
—
23
37
291
3142
57
214
232
2898
63
447
169
2308
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-7.2e-02
9.2e-02
8.2e-01
2.3e+00
2.0e+00
7.8e-01
-1.1e-01
cases:41.19%
controls:42.96%
cases:34.59%
controls:32.55%
cases:11.95%
controls:5.66%
cases:2.52%
controls:0.25%
cases:29.94%
controls:5.28%
cases:53.98%
controls:34.93%
cases:60.34%
controls:62.83%
131
1366
187
1814
110
1035
208
2145
38
180
280
3000
8
8
310
3172
94
168
220
3011
156
1087
133
2025
140
1731
92
1024
Emergency Room and Inpatient Visit
ERIP [262]
3.8e-01
5.3e-02
2.3e+00
—
2.2e+00
1.4e+00
4.5e-01
cases:5.66%
controls:3.93%
cases:3.14%
controls:2.99%
cases:2.52%
controls:0.25%
—
—
cases:2.55%
controls:0.28%
cases:13.15%
controls:3.57%
cases:19.40%
controls:13.36%
18
125
300
3055
10
95
308
3085
8
8
310
3172
—
8
9
306
3170
38
111
251
3001
45
368
187
2387
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.4e-01
5.6e-01
2.5e+00
—
—
2.4e+00
1.1e+00
cases:5.97%
controls:3.58%
cases:3.77%
controls:2.20%
cases:2.52%
controls:0.22%
—
—
—
—
cases:14.53%
controls:1.57%
cases:15.09%
controls:5.63%
19
114
299
3066
12
70
306
3110
8
7
310
3173
—
—
42
49
247
3063
35
155
197
2600
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.5e-01
4.7e-01
1.5e+00
—
2.3e+00
1.5e+00
5.2e-01
cases:15.09%
controls:10.16%
cases:8.49%
controls:5.47%
cases:2.83%
controls:0.63%
—
—
cases:5.41%
controls:0.57%
cases:23.18%
controls:6.04%
cases:27.16%
controls:18.11%
48
323
270
2857
27
174
291
3006
9
20
309
3160
—
17
18
297
3161
67
188
222
2924
63
499
169
2256
Basophils [#/volume] in Blood
26444-0 [3006315]
2.5e-01
8.2e-01
1.6e+00
—
1.8e+00
1.1e+00
5.4e-01
cases:13.52%
controls:10.82%
cases:15.41%
controls:7.42%
cases:6.60%
controls:1.38%
—
—
cases:7.01%
controls:1.26%
cases:19.72%
controls:7.26%
cases:28.45%
controls:18.87%
43
344
275
2836
49
236
269
2944
21
44
297
3136
—
22
40
292
3139
57
226
232
2886
66
520
166
2235
Plastic And Reconstructive Surgery
24 [38004467]
9.3e-01
1.9e+00
—
—
—
2.3e+00
1.7e+00
cases:4.40%
controls:1.79%
cases:3.14%
controls:0.47%
—
—
—
—
—
—
cases:4.15%
controls:0.45%
cases:9.48%
controls:1.89%
14
57
304
3123
10
15
308
3165
—
—
—
12
14
277
3098
22
52
210
2703
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.8e-01
5.1e-01
1.1e+00
—
2.9e+00
1.9e+00
3.9e-01
cases:25.79%
controls:22.42%
cases:18.87%
controls:12.30%
cases:6.29%
controls:2.26%
—
—
cases:25.80%
controls:1.86%
cases:48.10%
controls:12.53%
cases:40.95%
controls:31.98%
82
713
236
2467
60
391
258
2789
20
72
298
3108
—
81
59
233
3120
139
390
150
2722
95
881
137
1874
Monocytes [#/volume] in Blood
26484-6 [3001604]
2.6e-01
8.1e-01
1.5e+00
—
1.8e+00
1.1e+00
5.5e-01
cases:13.52%
controls:10.72%
cases:15.09%
controls:7.36%
cases:6.29%
controls:1.42%
—
—
cases:7.01%
controls:1.23%
cases:19.38%
controls:7.20%
cases:28.45%
controls:18.73%
43
341
275
2839
48
234
270
2946
20
45
298
3135
—
22
39
292
3140
56
224
233
2888
66
516
166
2239
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
8.6e-02
7.4e-01
1.5e+00
—
1.9e+00
1.1e+00
6.0e-01
cases:11.95%
controls:11.07%
cases:14.15%
controls:7.30%
cases:5.97%
controls:1.45%
—
—
cases:7.32%
controls:1.20%
cases:19.03%
controls:7.07%
cases:27.16%
controls:16.95%
38
352
280
2828
45
232
273
2948
19
46
299
3134
—
23
38
291
3141
55
220
234
2892
63
467
169
2288
Medical doctor
Z2221 [2001311556]
7.1e-01
1.6e+00
—
1.0e+50
—
2.5e+00
1.7e+00
cases:8.81%
controls:4.53%
cases:4.72%
controls:0.97%
—
—
cases:1.89%
controls:0.00%
—
—
cases:7.96%
controls:0.74%
cases:9.05%
controls:1.71%
28
144
290
3036
15
31
303
3149
—
6
0
312
3180
—
23
23
266
3089
21
47
211
2708
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.1e-01
8.4e-01
1.4e+00
—
1.8e+00
1.1e+00
5.6e-01
cases:11.95%
controls:10.82%
cases:15.09%
controls:7.11%
cases:5.66%
controls:1.42%
—
—
cases:6.69%
controls:1.13%
cases:18.69%
controls:6.91%
cases:25.86%
controls:16.59%
38
344
280
2836
48
226
270
2954
18
45
300
3135
—
21
36
293
3143
54
215
235
2897
60
457
172
2298
Physiotherapist
Z3226 [2001311560]
4.3e-01
2.1e+00
—
—
—
3.7e+00
9.4e-01
cases:3.14%
controls:2.08%
cases:2.20%
controls:0.28%
—
—
—
—
—
—
cases:10.38%
controls:0.29%
cases:3.02%
controls:1.20%
10
66
308
3114
7
9
311
3171
—
—
—
30
9
259
3103
7
33
225
2722
ABO and Rh group [Type] in Blood
882-1 [3003694]
2.3e-01
4.7e-01
—
—
4.0e+00
1.7e+00
4.5e-01
cases:5.66%
controls:4.56%
cases:2.83%
controls:1.79%
—
—
—
—
cases:9.55%
controls:0.19%
cases:7.96%
controls:1.51%
cases:8.62%
controls:5.66%
18
145
300
3035
9
57
309
3123
—
—
30
6
284
3173
23
47
266
3065
20
156
212
2599
12 lead EKG panel
34534-8 [3044889]
-1.9e-01
-9.1e-02
2.5e+00
—
2.6e+00
5.6e-01
1.9e-01
cases:20.44%
controls:23.62%
cases:12.58%
controls:13.62%
cases:14.47%
controls:1.32%
—
—
cases:16.88%
controls:1.42%
cases:20.76%
controls:13.05%
cases:38.36%
controls:33.97%
65
751
253
2429
40
433
278
2747
46
42
272
3138
—
53
45
261
3134
60
406
229
2706
89
936
143
1819
Short blood count panel - Blood
55429-5 [40758558]
3.6e-01
5.9e-01
1.0e+00
—
3.4e+00
2.4e+00
5.5e-01
cases:7.55%
controls:5.41%
cases:5.03%
controls:2.86%
cases:1.57%
controls:0.57%
—
—
cases:10.51%
controls:0.41%
cases:20.07%
controls:2.28%
cases:13.79%
controls:8.46%
24
172
294
3008
16
91
302
3089
5
18
313
3162
—
33
13
281
3166
58
71
231
3041
32
233
200
2522
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.5e-01
7.6e-01
1.6e+00
—
1.7e+00
1.1e+00
5.4e-01
cases:14.15%
controls:11.42%
cases:15.09%
controls:7.67%
cases:6.60%
controls:1.48%
—
—
cases:7.32%
controls:1.38%
cases:20.07%
controls:7.55%
cases:29.31%
controls:19.46%
45
363
273
2817
48
244
270
2936
21
47
297
3133
—
23
44
291
3135
58
235
231
2877
68
536
164
2219
Immunohistochemistry procedure
117617002 [4035726]
1.1e+00
2.8e+00
—
1.0e+50
—
—
2.9e+00
cases:1.57%
controls:0.50%
cases:3.46%
controls:0.22%
—
—
cases:23.27%
controls:0.00%
—
—
—
—
cases:7.33%
controls:0.44%
5
16
313
3164
11
7
307
3173
—
74
0
244
3180
—
—
17
12
215
2743
Intraoral radiographic dental examination
EB1AA [2001301903]
-9.9e-02
4.9e-01
1.9e+00
—
2.3e+00
7.8e-01
6.7e-01
cases:16.04%
controls:17.42%
cases:8.81%
controls:5.57%
cases:3.46%
controls:0.53%
—
—
cases:5.73%
controls:0.60%
cases:12.46%
controls:6.14%
cases:25.43%
controls:14.88%
51
554
267
2626
28
177
290
3003
11
17
307
3163
—
18
19
296
3160
36
191
253
2921
59
410
173
2345
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.5e-02
6.3e-01
1.6e+00
—
1.8e+00
1.3e+00
8.8e-01
cases:6.92%
controls:6.76%
cases:8.49%
controls:4.72%
cases:3.77%
controls:0.82%
—
—
cases:5.10%
controls:0.88%
cases:14.19%
controls:4.37%
cases:21.98%
controls:10.49%
22
215
296
2965
27
150
291
3030
12
26
306
3154
—
16
28
298
3151
41
136
248
2976
51
289
181
2466
Emergency Room Visit
ER [9203]
1.5e-01
4.0e-01
2.0e+00
1.0e+50
1.6e+00
1.4e+00
4.9e-01
cases:37.74%
controls:34.25%
cases:15.09%
controls:10.66%
cases:7.86%
controls:1.13%
cases:1.89%
controls:0.00%
cases:7.32%
controls:1.51%
cases:29.76%
controls:9.67%
cases:33.19%
controls:23.27%
120
1089
198
2091
48
339
270
2841
25
36
293
3144
6
0
312
3180
23
48
291
3131
86
301
203
2811
77
641
155
2114
EKG study
11524-6 [3013512]
-1.2e-02
1.8e-01
2.1e+00
1.0e+50
2.6e+00
7.1e-01
6.7e-02
cases:8.81%
controls:8.90%
cases:6.60%
controls:5.60%
cases:5.35%
controls:0.69%
cases:2.52%
controls:0.00%
cases:6.69%
controls:0.53%
cases:10.73%
controls:5.56%
cases:15.52%
controls:14.66%
28
283
290
2897
21
178
297
3002
17
22
301
3158
8
0
310
3180
21
17
293
3162
31
173
258
2939
36
404
196
2351
sodium fluoride; oral
A01AA01 [21600005]
8.6e-01
—
—
—
—
3.0e+00
2.3e+00
cases:2.20%
controls:0.94%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.55%
cases:12.50%
controls:1.42%
7
30
311
3150
—
—
—
—
28
17
261
3095
29
39
203
2716
Preventive oral health care
SCA02 [2001310303]
—
-1.0e+50
—
—
—
3.4e+00
1.9e+00
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
cases:6.92%
controls:0.26%
cases:7.33%
controls:1.20%
—
0
10
318
3170
—
—
—
20
8
269
3104
17
33
215
2722
Bacteria identified in Blood by Culture
600-7 [3023368]
2.3e-01
-2.8e-01
—
—
2.4e+00
2.1e+00
6.9e-01
cases:5.97%
controls:4.81%
cases:1.57%
controls:2.08%
—
—
—
—
cases:3.82%
controls:0.35%
cases:15.22%
controls:2.22%
cases:14.66%
controls:7.91%
19
153
299
3027
5
66
313
3114
—
—
12
11
302
3168
44
69
245
3043
34
218
198
2537
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
2.2e-01
8.5e-01
—
—
3.5e+00
1.7e+00
5.6e-01
cases:6.29%
controls:5.09%
cases:2.83%
controls:1.23%
—
—
—
—
cases:5.10%
controls:0.16%
cases:6.23%
controls:1.25%
cases:7.33%
controls:4.32%
20
162
298
3018
9
39
309
3141
—
—
16
5
298
3174
18
39
271
3073
17
119
215
2636
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
6.2e-01
—
—
—
—
2.8e+00
2.3e+00
cases:3.46%
controls:1.89%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.64%
cases:21.55%
controls:2.58%
11
60
307
3120
—
—
—
—
28
20
261
3092
50
71
182
2684
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.4e-01
7.8e-01
1.5e+00
—
1.8e+00
1.1e+00
5.0e-01
cases:13.21%
controls:11.70%
cases:15.41%
controls:7.67%
cases:6.29%
controls:1.51%
—
—
cases:7.32%
controls:1.29%
cases:19.38%
controls:7.58%
cases:28.02%
controls:19.17%
42
372
276
2808
49
244
269
2936
20
48
298
3132
—
23
41
291
3138
56
236
233
2876
65
528
167
2227
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.6e-01
8.2e-01
—
—
2.9e+00
2.2e+00
7.3e-01
cases:3.14%
controls:2.45%
cases:3.14%
controls:1.42%
—
—
—
—
cases:4.46%
controls:0.25%
cases:11.42%
controls:1.45%
cases:8.19%
controls:4.14%
10
78
308
3102
10
45
308
3135
—
—
14
8
300
3171
33
45
256
3067
19
114
213
2641
Pathology report gross observation
24419-4 [3002256]
1.3e+00
—
—
—
—
2.2e+00
1.6e+00
cases:5.03%
controls:1.48%
—
—
—
—
—
—
—
—
cases:6.57%
controls:0.77%
cases:8.62%
controls:1.85%
16
47
302
3133
—
—
—
—
19
24
270
3088
20
51
212
2704
dexamethasone; oral, parenteral
H02AB02 [21602730]
8.5e-02
7.4e-01
—
—
—
3.6e+00
1.4e+00
cases:1.57%
controls:1.45%
cases:1.57%
controls:0.75%
—
—
—
—
—
—
cases:20.07%
controls:0.71%
cases:9.91%
controls:2.54%
5
46
313
3134
5
24
313
3156
—
—
—
58
22
231
3090
23
70
209
2685
Caries of dentine
K02.1 [45548134]
-1.2e-01
1.0e-01
1.0e+00
—
2.8e+00
1.2e+00
8.5e-01
cases:17.30%
controls:19.06%
cases:7.86%
controls:7.17%
cases:2.52%
controls:0.94%
—
—
cases:13.38%
controls:0.91%
cases:21.45%
controls:7.39%
cases:36.64%
controls:19.75%
55
606
263
2574
25
228
293
2952
8
30
310
3150
—
42
29
272
3150
62
230
227
2882
85
544
147
2211
Normoblasts [#/volume] in Blood
715-3 [3021589]
-1.3e-02
4.8e-01
1.7e+00
—
2.1e+00
1.1e+00
4.0e-01
cases:8.18%
controls:8.27%
cases:12.26%
controls:7.99%
cases:7.23%
controls:1.45%
—
—
cases:10.83%
controls:1.51%
cases:21.80%
controls:8.35%
cases:27.59%
controls:20.36%
26
263
292
2917
39
254
279
2926
23
46
295
3134
—
34
48
280
3131
63
260
226
2852
64
561
168
2194
Removal of sutures from oral mucosa
SXB00 [2001310580]
—
—
—
—
1.0e+50
2.9e+00
1.9e+00
—
—
—
—
—
—
—
—
cases:1.59%
controls:0.00%
cases:3.81%
controls:0.22%
cases:3.45%
controls:0.51%
—
—
—
—
5
0
309
3179
11
7
278
3105
8
14
224
2741
Cathetrisation of vein
TPH04 [2001309597]
7.6e-01
3.6e-01
—
—
2.7e+00
1.9e+00
7.2e-01
cases:5.03%
controls:2.42%
cases:1.57%
controls:1.10%
—
—
—
—
cases:2.87%
controls:0.19%
cases:6.57%
controls:1.00%
cases:7.76%
controls:3.92%
16
77
302
3103
5
35
313
3145
—
—
9
6
305
3173
19
31
270
3081
18
108
214
2647
nystatin; oral
A07AA02 [21600604]
1.7e+00
—
—
—
—
—
3.0e+00
cases:3.77%
controls:0.72%
—
—
—
—
—
—
—
—
—
—
cases:9.91%
controls:0.54%
12
23
306
3157
—
—
—
—
—
23
15
209
2740
Pharmacy visit
OMOP4822462 [581458]
1.5e-01
3.7e-01
5.6e-01
1.4e+00
1.3e+00
1.4e+00
1.2e+00
cases:93.71%
controls:92.74%
cases:89.94%
controls:86.04%
cases:64.15%
controls:50.47%
cases:10.06%
controls:2.77%
cases:79.94%
controls:51.18%
cases:96.54%
controls:87.69%
cases:98.71%
controls:95.79%
298
2949
20
231
286
2736
32
444
204
1605
114
1575
32
88
286
3092
251
1627
63
1552
279
2729
10
383
229
2639
3
116
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.1e+00
—
—
—
—
2.8e+00
1.8e+00
cases:2.52%
controls:0.85%
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.19%
cases:3.88%
controls:0.65%
8
27
310
3153
—
—
—
—
9
6
280
3106
9
18
223
2737
ibuprofen
R02AX02 [1588667]
0.0e+00
1.9e-01
1.4e+00
—
2.4e+00
8.0e-01
2.0e-01
cases:34.28%
controls:34.28%
cases:17.30%
controls:14.69%
cases:8.49%
controls:2.23%
—
—
cases:18.79%
controls:2.08%
cases:27.68%
controls:14.62%
cases:35.34%
controls:31.00%
109
1090
209
2090
55
467
263
2713
27
71
291
3109
—
59
66
255
3113
80
455
209
2657
82
854
150
1901
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
0.0e+00
1.9e-01
1.4e+00
—
2.4e+00
8.0e-01
2.0e-01
cases:34.28%
controls:34.28%
cases:17.30%
controls:14.69%
cases:8.49%
controls:2.23%
—
—
cases:18.79%
controls:2.08%
cases:27.68%
controls:14.62%
cases:35.34%
controls:31.00%
109
1090
209
2090
55
467
263
2713
27
71
291
3109
—
59
66
255
3113
80
455
209
2657
82
854
150
1901
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
—
—
—
—
—
4.6e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:17.99%
controls:0.22%
cases:2.59%
controls:1.02%
—
—
—
—
—
52
7
237
3105
6
28
226
2727
Extensive body CT
JN4BD [2001310899]
1.7e+00
—
—
—
—
—
2.9e+00
cases:2.52%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:0.25%
8
15
310
3165
—
—
—
—
—
10
7
222
2748
metronidazole and furazolidone
P01AB51 [45893518]
1.6e+00
—
—
—
—
1.0e+50
2.8e+00
cases:2.52%
controls:0.50%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.00%
cases:3.45%
controls:0.22%
8
16
310
3164
—
—
—
—
28
0
261
3112
8
6
224
2749
nystatin; vaginal
G01AA01 [21602363]
1.6e+00
—
—
—
—
1.0e+50
2.8e+00
cases:2.52%
controls:0.50%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.00%
cases:3.45%
controls:0.22%
8
16
310
3164
—
—
—
—
28
0
261
3112
8
6
224
2749
triamcinolone and antiinfectives
S02CA04 [21605176]
1.6e+00
—
—
—
—
1.0e+50
2.8e+00
cases:2.52%
controls:0.50%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.00%
cases:3.45%
controls:0.22%
8
16
310
3164
—
—
—
—
28
0
261
3112
8
6
224
2749
nystatin
D01AA01 [21601911]
1.6e+00
—
—
—
—
1.0e+50
2.8e+00
cases:2.52%
controls:0.50%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.00%
cases:3.45%
controls:0.22%
8
16
310
3164
—
—
—
—
28
0
261
3112
8
6
224
2749
Teaching
WZC30 [2001310891]
-7.8e-02
7.8e-01
—
—
—
3.4e+00
1.0e+00
cases:1.57%
controls:1.70%
cases:1.57%
controls:0.72%
—
—
—
—
—
—
cases:16.96%
controls:0.71%
cases:6.90%
controls:2.61%
5
54
313
3126
5
23
313
3157
—
—
—
49
22
240
3090
16
72
216
2683
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.0e-01
2.6e-01
1.2e+00
—
2.1e+00
1.6e+00
6.2e-01
cases:13.21%
controls:9.28%
cases:6.29%
controls:4.94%
cases:1.89%
controls:0.57%
—
—
cases:4.14%
controls:0.53%
cases:21.11%
controls:5.11%
cases:25.43%
controls:15.46%
42
295
276
2885
20
157
298
3023
6
18
312
3162
—
13
17
301
3162
61
159
228
2953
59
426
173
2329
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.2e-01
6.5e-01
2.3e+00
—
—
2.0e+00
7.0e-01
cases:4.09%
controls:2.74%
cases:2.20%
controls:1.16%
cases:1.89%
controls:0.19%
—
—
—
—
cases:6.23%
controls:0.90%
cases:5.60%
controls:2.87%
13
87
305
3093
7
37
311
3143
6
6
312
3174
—
—
18
28
271
3084
13
79
219
2676
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.0e-01
1.3e+00
—
—
—
2.2e+00
8.2e-01
cases:4.09%
controls:2.08%
cases:3.46%
controls:0.94%
—
—
—
—
—
—
cases:7.27%
controls:0.90%
cases:11.21%
controls:5.26%
13
66
305
3114
11
30
307
3150
—
—
—
21
28
268
3084
26
145
206
2610
Neck ultrasound examination
EP1AE [2001302284]
—
—
1.0e+50
—
1.0e+50
—
4.3e+00
—
—
—
—
cases:2.52%
controls:0.00%
—
—
cases:1.59%
controls:0.00%
—
—
cases:20.69%
controls:0.36%
—
—
8
0
310
3180
—
5
0
309
3179
—
48
10
184
2745
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2.1e+00
1.8e+00
—
—
—
—
2.1e+00
cases:2.52%
controls:0.31%
cases:1.57%
controls:0.25%
—
—
—
—
—
—
—
—
cases:6.47%
controls:0.83%
8
10
310
3170
5
8
313
3172
—
—
—
—
15
23
217
2732
temazepam; oral
N05CD07 [21604642]
6.0e-01
1.2e+00
1.4e+00
—
1.6e+00
1.3e+00
8.5e-01
cases:5.97%
controls:3.36%
cases:5.35%
controls:1.67%
cases:1.57%
controls:0.41%
—
—
cases:2.87%
controls:0.60%
cases:6.57%
controls:1.80%
cases:7.76%
controls:3.48%
19
107
299
3073
17
53
301
3127
5
13
313
3167
—
9
19
305
3160
19
56
270
3056
18
96
214
2659
Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8099-4 [3027238]
—
1.4e+00
—
—
—
2.3e+00
1.8e+00
—
—
cases:1.57%
controls:0.38%
—
—
—
—
—
—
cases:2.42%
controls:0.26%
cases:5.17%
controls:0.91%
—
5
12
313
3168
—
—
—
7
8
282
3104
12
25
220
2730
antibiotics in combination with corticosteroids
D01AA20 [21601918]
5.2e-01
—
—
—
—
4.0e+00
1.2e+00
cases:2.52%
controls:1.51%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.19%
cases:3.88%
controls:1.23%
8
48
310
3132
—
—
—
—
28
6
261
3106
9
34
223
2721
Dental examination
Z01.2 [45581002]
-3.4e-02
5.8e-01
—
—
2.3e+00
1.1e+00
5.8e-01
cases:9.12%
controls:9.40%
cases:5.97%
controls:3.43%
—
—
—
—
cases:3.18%
controls:0.31%
cases:9.69%
controls:3.57%
cases:20.69%
controls:12.74%
29
299
289
2881
19
109
299
3071
—
—
10
10
304
3169
28
111
261
3001
48
351
184
2404
General anaesthesia
WX402 [2001310806]
5.7e-01
1.1e+00
—
1.0e+50
—
2.8e+00
1.2e+00
cases:2.20%
controls:1.26%
cases:3.14%
controls:1.10%
—
—
cases:5.97%
controls:0.00%
—
—
cases:11.42%
controls:0.80%
cases:13.36%
controls:4.43%
7
40
311
3140
10
35
308
3145
—
19
0
299
3180
—
33
25
256
3087
31
122
201
2633
fluconazole; oral, parenteral
J02AC01 [21603080]
7.1e-01
8.7e-01
—
—
—
2.6e+00
1.3e+00
cases:6.92%
controls:3.52%
cases:2.52%
controls:1.07%
—
—
—
—
—
—
cases:12.11%
controls:1.03%
cases:8.62%
controls:2.40%
22
112
296
3068
8
34
310
3146
—
—
—
35
32
254
3080
20
66
212
2689
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.4e-03
7.5e-02
9.5e-01
—
1.9e+00
1.0e+00
1.8e-01
cases:36.79%
controls:36.76%
cases:21.07%
controls:19.84%
cases:9.75%
controls:4.03%
—
—
cases:21.34%
controls:3.81%
cases:41.18%
controls:20.37%
cases:48.28%
controls:43.74%
117
1169
201
2011
67
631
251
2549
31
128
287
3052
—
67
121
247
3058
119
634
170
2478
112
1205
120
1550
dexamethasone and antiinfectives
S02CA06 [21605178]
1.2e+00
—
—
—
—
3.9e+00
1.2e+00
cases:3.14%
controls:1.01%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.22%
cases:4.74%
controls:1.42%
10
32
308
3148
—
—
—
—
28
7
261
3105
11
39
221
2716
Clinic/Center
261Q00000X [38004207]
—
—
—
—
—
3.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:6.92%
controls:0.16%
—
—
—
—
—
—
—
20
5
269
3107
—
tinzaparin; parenteral
B01AB10 [21600981]
—
—
—
—
—
2.7e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:4.15%
controls:0.29%
cases:5.60%
controls:1.89%
—
—
—
—
—
12
9
277
3103
13
52
219
2703
Localized swelling, mass and lump, neck
R22.1 [45592412]
—
3.8e+00
1.0e+50
1.0e+50
1.0e+50
—
1.6e+00
—
—
cases:6.60%
controls:0.16%
cases:13.52%
controls:0.00%
cases:4.40%
controls:0.00%
cases:8.60%
controls:0.00%
—
—
cases:2.59%
controls:0.54%
—
21
5
297
3175
43
0
275
3180
14
0
304
3180
27
0
287
3179
—
6
15
226
2740
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
9.2e-01
9.7e-01
—
—
—
1.8e+00
1.0e+00
cases:5.66%
controls:2.33%
cases:1.89%
controls:0.72%
—
—
—
—
—
—
cases:4.84%
controls:0.84%
cases:7.76%
controls:2.94%
18
74
300
3106
6
23
312
3157
—
—
—
14
26
275
3086
18
81
214
2674
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
3.7e-01
5.4e-01
2.3e+00
—
—
1.4e+00
5.2e-01
cases:4.40%
controls:3.08%
cases:2.52%
controls:1.48%
cases:1.89%
controls:0.19%
—
—
—
—
cases:5.54%
controls:1.41%
cases:6.47%
controls:3.96%
14
98
304
3082
8
47
310
3133
6
6
312
3174
—
—
16
44
273
3068
15
109
217
2646
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
1.8e-01
8.1e-01
—
—
2.3e+00
1.3e+00
5.8e-01
cases:9.75%
controls:8.24%
cases:5.03%
controls:2.30%
—
—
—
—
cases:2.23%
controls:0.22%
cases:6.92%
controls:1.93%
cases:10.78%
controls:6.35%
31
262
287
2918
16
73
302
3107
—
—
7
7
307
3172
20
60
269
3052
25
175
207
2580
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
1.5e+00
—
—
—
—
2.1e+00
1.5e+00
cases:2.20%
controls:0.50%
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.39%
cases:7.76%
controls:1.81%
7
16
311
3164
—
—
—
—
9
12
280
3100
18
50
214
2705
Periodontitis pronounced
K05.31 [2000502729]
9.4e-01
—
—
—
—
2.3e+00
1.3e+00
cases:3.46%
controls:1.38%
—
—
—
—
—
—
—
—
cases:8.30%
controls:0.90%
cases:7.76%
controls:2.21%
11
44
307
3136
—
—
—
—
24
28
265
3084
18
61
214
2694
Basic examination of mouth
SAA02 [2001310275]
-2.9e-01
4.9e-02
1.2e+00
—
1.9e+00
9.3e-01
7.1e-01
cases:16.04%
controls:20.28%
cases:7.86%
controls:7.52%
cases:2.20%
controls:0.69%
—
—
cases:5.41%
controls:0.85%
cases:14.88%
controls:6.43%
cases:39.22%
controls:24.14%
51
645
267
2535
25
239
293
2941
7
22
311
3158
—
17
27
297
3152
43
200
246
2912
91
665
141
2090
Sedation and analgesia
WX002 [2001310758]
3.0e-01
7.8e-01
—
—
—
2.4e+00
1.1e+00
cases:4.09%
controls:3.05%
cases:1.57%
controls:0.72%
—
—
—
—
—
—
cases:7.61%
controls:0.71%
cases:6.03%
controls:2.18%
13
97
305
3083
5
23
313
3157
—
—
—
22
22
267
3090
14
60
218
2695
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.5e+00
—
—
—
—
2.0e+00
8.0e-01
cases:3.46%
controls:0.75%
—
—
—
—
—
—
—
—
cases:4.15%
controls:0.61%
cases:6.90%
controls:3.23%
11
24
307
3156
—
—
—
—
12
19
277
3093
16
89
216
2666
Extraction of tooth
EBA00 [2001301923]
1.5e-01
5.4e-01
—
—
3.5e+00
6.4e-01
4.3e-01
cases:9.75%
controls:8.52%
cases:4.40%
controls:2.61%
—
—
—
—
cases:7.64%
controls:0.25%
cases:4.84%
controls:2.60%
cases:12.07%
controls:8.20%
31
271
287
2909
14
83
304
3097
—
—
24
8
290
3171
14
81
275
3031
28
226
204
2529
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
—
1.2e+00
—
—
—
2.1e+00
1.4e+00
—
—
cases:1.89%
controls:0.60%
—
—
—
—
—
—
cases:3.11%
controls:0.39%
cases:6.90%
controls:1.85%
—
6
19
312
3161
—
—
—
9
12
280
3100
16
51
216
2704
amoxicillin; oral, parenteral
J01CA04 [21602823]
-1.4e-02
1.6e-01
9.3e-01
—
1.6e+00
1.0e+00
8.5e-01
cases:20.13%
controls:20.35%
cases:6.60%
controls:5.69%
cases:1.57%
controls:0.63%
—
—
cases:3.18%
controls:0.66%
cases:15.22%
controls:6.14%
cases:34.48%
controls:18.37%
64
647
254
2533
21
181
297
2999
5
20
313
3160
—
10
21
304
3158
44
191
245
2921
80
506
152
2249
Counselling and guidance which enhance independent living
R2130 [2001310196]
7.3e-01
1.3e+00
—
—
—
3.4e+00
1.3e+00
cases:2.20%
controls:1.07%
cases:1.89%
controls:0.53%
—
—
—
—
—
—
cases:11.42%
controls:0.42%
cases:4.31%
controls:1.16%
7
34
311
3146
6
17
312
3163
—
—
—
33
13
256
3099
10
32
222
2723
mirtazapine; oral
N06AX11 [21604740]
5.7e-01
1.0e+00
1.3e+00
—
1.3e+00
1.1e+00
2.7e-01
cases:10.06%
controls:5.94%
cases:8.81%
controls:3.43%
cases:3.46%
controls:1.01%
—
—
cases:3.82%
controls:1.07%
cases:10.03%
controls:3.57%
cases:10.78%
controls:8.42%
32
189
286
2991
28
109
290
3071
11
32
307
3148
—
12
34
302
3145
29
111
260
3001
25
232
207
2523
Simple examination of mouth
SAA01 [2001310274]
-1.6e-01
2.9e-01
1.2e+00
—
1.5e+00
6.8e-01
4.6e-01
cases:23.58%
controls:26.64%
cases:14.78%
controls:11.48%
cases:5.97%
controls:1.79%
—
—
cases:6.69%
controls:1.60%
cases:22.49%
controls:12.85%
cases:39.22%
controls:28.93%
75
847
243
2333
47
365
271
2815
19
57
299
3123
—
21
51
293
3128
65
400
224
2712
91
797
141
1958
Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]
-2.2e-01
—
—
—
—
2.2e+00
1.2e+00
cases:4.72%
controls:5.82%
—
—
—
—
—
—
—
—
cases:3.81%
controls:0.45%
cases:5.17%
controls:1.56%
15
185
303
2995
—
—
—
—
11
14
278
3098
12
43
220
2712
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
5.2e-01
1.2e+00
—
—
—
2.2e+00
1.1e+00
cases:1.57%
controls:0.94%
cases:1.57%
controls:0.47%
—
—
—
—
—
—
cases:3.11%
controls:0.35%
cases:6.47%
controls:2.21%
5
30
313
3150
5
15
313
3165
—
—
—
9
11
280
3101
15
61
217
2694
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
7.7e-01
—
—
—
—
2.2e+00
1.1e+00
cases:1.89%
controls:0.88%
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.35%
cases:6.47%
controls:2.25%
6
28
312
3152
—
—
—
—
9
11
280
3101
15
62
217
2693
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
-2.0e-02
—
—
—
—
3.3e+00
5.9e-01
cases:1.57%
controls:1.60%
—
—
—
—
—
—
—
—
cases:10.03%
controls:0.42%
cases:3.88%
controls:2.18%
5
51
313
3129
—
—
—
—
29
13
260
3099
9
60
223
2695
magnesium hydroxide; oral
G04BX01 [21602658]
—
—
—
—
—
3.2e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:6.23%
controls:0.26%
cases:2.16%
controls:0.36%
—
—
—
—
—
18
8
271
3104
5
10
227
2745
magnesium hydroxide; oral
A02AA04 [21600052]
—
—
—
—
—
3.2e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:6.23%
controls:0.26%
cases:2.16%
controls:0.36%
—
—
—
—
—
18
8
271
3104
5
10
227
2745
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
7.7e-01
—
—
—
—
2.1e+00
1.1e+00
cases:1.89%
controls:0.88%
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.39%
cases:6.47%
controls:2.32%
6
28
312
3152
—
—
—
—
9
12
280
3100
15
64
217
2691
Audiology
64 [38004489]
2.5e-01
7.5e-01
—
—
—
2.2e+00
9.5e-01
cases:4.09%
controls:3.21%
cases:2.83%
controls:1.35%
—
—
—
—
—
—
cases:11.07%
controls:1.35%
cases:9.48%
controls:3.88%
13
102
305
3078
9
43
309
3137
—
—
—
32
42
257
3070
22
107
210
2648
Caries limited to enamel
K02.0 [45576967]
6.3e-02
—
—
—
—
2.1e+00
1.0e+00
cases:1.57%
controls:1.48%
—
—
—
—
—
—
—
—
cases:5.19%
controls:0.64%
cases:8.19%
controls:3.16%
5
47
313
3133
—
—
—
—
15
20
274
3092
19
87
213
2668
CT examination of mouth and soft tissues of neck
EN1AD [2001302280]
—
—
—
—
1.0e+50
1.0e+50
3.1e+00
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.00%
cases:1.73%
controls:0.00%
cases:4.74%
controls:0.22%
—
—
—
—
6
0
308
3179
5
0
284
3112
11
6
221
2749
Other blockage of nerve
WX290 [2001310792]
6.6e-02
2.2e-01
1.4e+00
—
3.1e+00
5.8e-02
2.1e-01
cases:11.01%
controls:10.38%
cases:3.77%
controls:3.05%
cases:1.57%
controls:0.38%
—
—
cases:5.41%
controls:0.25%
cases:3.81%
controls:3.60%
cases:12.93%
controls:10.74%
35
330
283
2850
12
97
306
3083
5
12
313
3168
—
17
8
297
3171
11
112
278
3000
30
296
202
2459
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.2e-01
4.4e-01
1.3e+00
—
1.8e+00
2.9e-01
1.1e-01
cases:21.07%
controls:17.70%
cases:14.15%
controls:9.56%
cases:4.09%
controls:1.16%
—
—
cases:5.41%
controls:0.91%
cases:11.76%
controls:9.06%
cases:28.45%
controls:26.24%
67
563
251
2617
45
304
273
2876
13
37
305
3143
—
17
29
297
3150
34
282
255
2830
66
723
166
2032
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
2.1e-01
3.4e-01
—
—
1.9e+00
2.3e+00
7.6e-01
cases:3.46%
controls:2.83%
cases:2.20%
controls:1.57%
—
—
—
—
cases:1.91%
controls:0.28%
cases:11.42%
controls:1.25%
cases:11.64%
controls:5.81%
11
90
307
3090
7
50
311
3130
—
—
6
9
308
3170
33
39
256
3073
27
160
205
2595
Preventive oral health care, short
SCA01 [2001310302]
-1.9e-01
6.8e-01
—
—
—
1.9e+00
1.2e+00
cases:4.40%
controls:5.25%
cases:2.20%
controls:1.13%
—
—
—
—
—
—
cases:7.61%
controls:1.22%
cases:11.64%
controls:3.96%
14
167
304
3013
7
36
311
3144
—
—
—
22
38
267
3074
27
109
205
2646
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
-7.3e-03
2.7e-01
1.2e+00
—
1.1e+00
7.5e-01
4.3e-01
cases:31.13%
controls:31.29%
cases:22.64%
controls:18.21%
cases:6.60%
controls:2.14%
—
—
cases:6.05%
controls:2.04%
cases:32.53%
controls:18.54%
cases:55.17%
controls:44.46%
99
995
219
2185
72
579
246
2601
21
68
297
3112
—
19
65
295
3114
94
577
195
2535
128
1225
104
1530
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-1.3e-01
3.4e-01
1.4e+00
—
1.6e+00
2.6e-01
7.8e-02
cases:19.50%
controls:21.54%
cases:15.72%
controls:11.76%
cases:7.55%
controls:1.92%
—
—
cases:6.05%
controls:1.29%
cases:14.19%
controls:11.34%
cases:30.60%
controls:28.97%
62
685
256
2495
50
374
268
2806
24
61
294
3119
—
19
41
295
3138
41
353
248
2759
71
798
161
1957
lidocaine; ointment
D04AB01 [21602020]
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.16%
—
—
—
—
—
—
—
9
5
280
3107
—
lidocaine
C05AD01 [21601618]
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.16%
—
—
—
—
—
—
—
9
5
280
3107
—
Pain in throat
R07.0 [45592406]
9.3e-01
3.0e+00
—
—
—
—
—
cases:1.57%
controls:0.63%
cases:4.72%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
5
20
313
3160
15
8
303
3172
—
—
—
—
—
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
2.5e-01
9.3e-01
—
—
—
2.0e+00
9.8e-01
cases:1.89%
controls:1.48%
cases:1.89%
controls:0.75%
—
—
—
—
—
—
cases:4.50%
controls:0.64%
cases:8.62%
controls:3.41%
6
47
312
3133
6
24
312
3156
—
—
—
13
20
276
3092
20
94
212
2661
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
9.1e-01
—
—
—
—
1.8e+00
1.2e+00
cases:3.46%
controls:1.42%
—
—
—
—
—
—
—
—
cases:4.50%
controls:0.77%
cases:7.33%
controls:2.43%
11
45
307
3135
—
—
—
—
13
24
276
3088
17
67
215
2688
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
1.8e-02
4.1e-01
1.3e+00
—
6.5e-01
9.2e-01
7.8e-01
cases:22.01%
controls:21.70%
cases:17.30%
controls:12.14%
cases:5.35%
controls:1.57%
—
—
cases:2.55%
controls:1.35%
cases:26.30%
controls:12.50%
cases:49.57%
controls:31.14%
70
690
248
2490
55
386
263
2794
17
50
301
3130
—
8
43
306
3136
76
389
213
2723
115
858
117
1897
General Surgery
2 [38004447]
3.9e-01
4.4e-01
1.4e+00
1.0e+50
1.8e+00
1.1e+00
5.3e-01
cases:19.50%
controls:14.12%
cases:6.60%
controls:4.37%
cases:2.20%
controls:0.57%
cases:1.89%
controls:0.00%
cases:2.87%
controls:0.47%
cases:11.07%
controls:3.92%
cases:15.95%
controls:10.02%
62
449
256
2731
21
139
297
3041
7
18
311
3162
6
0
312
3180
9
15
305
3164
32
122
257
2990
37
276
195
2479
Palliative care
Z51.5 [45547323]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.47%
controls:0.36%
—
—
—
—
—
—
15
10
217
2745
Oxygen saturation in Arterial blood
2708-6 [3016502]
8.9e-02
8.1e-01
—
—
—
1.9e+00
1.1e+00
cases:1.89%
controls:1.73%
cases:1.89%
controls:0.85%
—
—
—
—
—
—
cases:4.84%
controls:0.77%
cases:9.48%
controls:3.52%
6
55
312
3125
6
27
312
3153
—
—
—
14
24
275
3088
22
97
210
2658
Clinical photography of mouth and teeth
SBB00 [2001310298]
—
—
1.0e+50
—
—
—
2.9e+00
—
—
—
—
cases:1.89%
controls:0.00%
—
—
—
—
—
—
cases:5.17%
controls:0.29%
—
—
6
0
312
3180
—
—
—
12
8
220
2747
Base excess in Arterial blood by calculation
1925-7 [3003396]
4.1e-01
8.3e-01
—
—
—
1.8e+00
1.0e+00
cases:3.14%
controls:2.11%
cases:2.20%
controls:0.97%
—
—
—
—
—
—
cases:4.84%
controls:0.80%
cases:9.91%
controls:3.88%
10
67
308
3113
7
31
311
3149
—
—
—
14
25
275
3087
23
107
209
2648
pH of Arterial blood
2744-1 [3019977]
4.3e-01
8.3e-01
—
—
—
1.8e+00
9.9e-01
cases:3.14%
controls:2.08%
cases:2.20%
controls:0.97%
—
—
—
—
—
—
cases:4.84%
controls:0.80%
cases:9.91%
controls:3.92%
10
66
308
3114
7
31
311
3149
—
—
—
14
25
275
3087
23
108
209
2647
Dental impressions
SBB10 [2001310299]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.76%
controls:0.51%
—
—
—
—
—
—
18
14
214
2741
dexamethasone and antiinfectives
S03CA01 [21605206]
5.5e-01
—
—
—
—
2.8e+00
8.5e-01
cases:4.09%
controls:2.39%
—
—
—
—
—
—
—
—
cases:10.38%
controls:0.71%
cases:6.47%
controls:2.87%
13
76
305
3104
—
—
—
—
30
22
259
3090
15
79
217
2676
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
1.0e+50
—
2.8e+00
—
—
—
—
—
—
—
—
cases:5.73%
controls:0.00%
—
—
cases:3.88%
controls:0.25%
—
—
—
—
18
0
296
3179
—
9
7
223
2748
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
4.1e-01
7.9e-01
—
—
—
1.8e+00
9.7e-01
cases:3.14%
controls:2.11%
cases:2.20%
controls:1.01%
—
—
—
—
—
—
cases:4.50%
controls:0.80%
cases:9.48%
controls:3.81%
10
67
308
3113
7
32
311
3148
—
—
—
13
25
276
3087
22
105
210
2650
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
4.1e-01
7.9e-01
—
—
—
1.8e+00
9.7e-01
cases:3.14%
controls:2.11%
cases:2.20%
controls:1.01%
—
—
—
—
—
—
cases:4.50%
controls:0.80%
cases:9.48%
controls:3.81%
10
67
308
3113
7
32
311
3148
—
—
—
13
25
276
3087
22
105
210
2650
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-3.1e-01
1.8e-01
1.8e+00
—
1.5e+00
8.8e-01
6.4e-02
cases:7.55%
controls:10.03%
cases:5.66%
controls:4.78%
cases:2.52%
controls:0.41%
—
—
cases:2.55%
controls:0.57%
cases:11.42%
controls:5.08%
cases:15.52%
controls:14.70%
24
319
294
2861
18
152
300
3028
8
13
310
3167
—
8
18
306
3161
33
158
256
2954
36
405
196
2350
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
1.8e+00
—
—
—
—
—
2.7e+00
cases:1.89%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:5.17%
controls:0.36%
6
10
312
3170
—
—
—
—
—
12
10
220
2745
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.59%
controls:0.18%
—
—
—
—
—
—
6
5
226
2750
Thorax extensive CT-examination
GD1BD [2001303621]
—
—
1.0e+50
—
1.0e+50
—
2.6e+00
—
—
—
—
cases:2.20%
controls:0.00%
—
—
cases:3.18%
controls:0.00%
—
—
cases:3.45%
controls:0.25%
—
—
7
0
311
3180
—
10
0
304
3179
—
8
7
224
2748
potassium chloride; oral
A12BA01 [21600877]
1.1e-01
—
—
—
—
1.5e+00
1.1e+00
cases:2.20%
controls:1.98%
—
—
—
—
—
—
—
—
cases:5.54%
controls:1.25%
cases:7.33%
controls:2.65%
7
63
311
3117
—
—
—
—
16
39
273
3073
17
73
215
2682
Internal Medicine
11 [38004456]
2.2e-01
5.4e-01
8.9e-01
—
1.4e+00
1.2e+00
4.4e-01
cases:25.79%
controls:21.82%
cases:13.21%
controls:8.18%
cases:3.46%
controls:1.45%
—
—
cases:4.78%
controls:1.20%
cases:21.45%
controls:7.90%
cases:26.29%
controls:18.73%
82
694
236
2486
42
260
276
2920
11
46
307
3134
—
15
38
299
3141
62
246
227
2866
61
516
171
2239
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
-1.0e+50
—
—
—
—
2.6e+00
1.1e+00
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.08%
controls:0.16%
cases:4.31%
controls:1.49%
0
7
318
3173
—
—
—
—
6
5
283
3107
10
41
222
2714
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
7.5e-03
2.7e-01
1.6e+00
—
1.5e+00
9.3e-01
1.5e-01
cases:4.40%
controls:4.37%
cases:3.46%
controls:2.67%
cases:2.52%
controls:0.50%
—
—
cases:1.91%
controls:0.44%
cases:6.57%
controls:2.70%
cases:9.05%
controls:7.88%
14
139
304
3041
11
85
307
3095
8
16
310
3164
—
6
14
308
3165
19
84
270
3028
21
217
211
2538
Dietary counselling and surveillance
Z71.3 [45552101]
—
—
—
—
1.0e+50
—
2.5e+00
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.00%
—
—
cases:3.88%
controls:0.33%
—
—
—
—
6
0
308
3179
—
9
9
223
2746
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
-2.1e-01
-3.2e-01
6.9e-01
2.5e+00
7.4e-01
-4.1e-01
-4.3e-01
cases:28.62%
controls:33.18%
cases:19.18%
controls:24.56%
cases:5.97%
controls:3.08%
cases:1.89%
controls:0.16%
cases:6.37%
controls:3.15%
cases:18.69%
controls:25.77%
cases:43.53%
controls:54.26%
91
1055
227
2125
61
781
257
2399
19
98
299
3082
6
5
312
3175
20
100
294
3079
54
802
235
2310
101
1495
131
1260
Operative extraction of tooth
EBA10 [2001301925]
2.5e-01
—
—
—
—
2.5e+00
1.3e+00
cases:1.57%
controls:1.23%
—
—
—
—
—
—
—
—
cases:4.15%
controls:0.35%
cases:3.02%
controls:0.87%
5
39
313
3141
—
—
—
—
12
11
277
3101
7
24
225
2731
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.25%
—
—
—
—
—
—
7
7
225
2748
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
TEW99 [2001302349]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.25%
—
—
—
—
—
—
7
7
225
2748
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-4.5e-02
1.0e+00
—
—
—
2.5e+00
8.2e-01
cases:2.83%
controls:2.96%
cases:1.57%
controls:0.57%
—
—
—
—
—
—
cases:6.92%
controls:0.61%
cases:6.03%
controls:2.76%
9
94
309
3086
5
18
313
3162
—
—
—
20
19
269
3093
14
76
218
2679
Lump/swelling localized
S04 [2002000969]
—
2.5e+00
—
—
—
-1.0e+50
9.1e-01
—
—
cases:2.52%
controls:0.22%
—
—
—
—
—
—
cases:0.00%
controls:0.35%
cases:3.02%
controls:1.23%
—
8
7
310
3173
—
—
—
0
11
289
3101
7
34
225
2721
Alcohol dependence continuous use
F10.25 [2000501682]
2.5e+00
—
—
—
—
—
—
cases:2.52%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
—
—
8
7
310
3173
—
—
—
—
—
—
Throat symptom/complaint
R21 [2002000891]
-9.7e-02
2.4e+00
1.0e+50
—
—
—
3.6e-03
cases:1.57%
controls:1.73%
cases:7.55%
controls:0.72%
cases:3.77%
controls:0.00%
—
—
—
—
—
—
cases:2.59%
controls:2.58%
5
55
313
3125
24
23
294
3157
12
0
306
3180
—
—
—
6
71
226
2684
fusidic acid; ointment
D06AX01 [21602062]
-8.0e-02
—
-1.0e+50
—
—
1.3e+00
1.1e+00
cases:3.14%
controls:3.40%
—
—
cases:0.00%
controls:0.16%
—
—
—
—
cases:3.81%
controls:1.03%
cases:9.91%
controls:3.63%
10
108
308
3072
—
0
5
318
3175
—
—
11
32
278
3080
23
100
209
2655
fusidic acid
D09AA02 [21602265]
-8.0e-02
—
-1.0e+50
—
—
1.3e+00
1.1e+00
cases:3.14%
controls:3.40%
—
—
cases:0.00%
controls:0.16%
—
—
—
—
cases:3.81%
controls:1.03%
cases:9.91%
controls:3.63%
10
108
308
3072
—
0
5
318
3175
—
—
11
32
278
3080
23
100
209
2655
Thorax CT examination
GD1AD [2001303618]
—
—
—
—
—
2.4e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.16%
cases:2.59%
controls:0.62%
—
—
—
—
—
5
5
284
3107
6
17
226
2738
Apolipoprotein B [Mass/volume] in Serum or Plasma
1884-6 [3014791]
—
—
—
—
—
2.4e+00
2.6e-01
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.16%
cases:2.16%
controls:1.67%
—
—
—
—
—
5
5
284
3107
5
46
227
2709
Preparing and fitting the occlusal splint in the mouth
SHB00 [2001310410]
—
—
—
—
—
2.4e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.16%
cases:3.02%
controls:0.65%
—
—
—
—
—
5
5
284
3107
7
18
225
2737
pregabalin; oral
N02BF02 [955152]
2.1e-01
9.1e-02
—
—
1.3e+00
1.4e+00
1.0e+00
cases:5.35%
controls:4.37%
cases:2.20%
controls:2.01%
—
—
—
—
cases:2.55%
controls:0.72%
cases:7.27%
controls:1.96%
cases:9.91%
controls:3.88%
17
139
301
3041
7
64
311
3116
—
—
8
23
306
3156
21
61
268
3051
23
107
209
2648
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.5e-01
3.3e-01
—
—
2.3e+00
7.6e-01
2.6e-01
cases:12.89%
controls:8.65%
cases:5.66%
controls:4.15%
—
—
—
—
cases:3.50%
controls:0.35%
cases:8.30%
controls:4.05%
cases:13.79%
controls:11.00%
41
275
277
2905
18
132
300
3048
—
—
11
11
303
3168
24
126
265
2986
32
303
200
2452
clindamycin
D10AF01 [21602305]
—
-1.0e+50
—
—
—
—
2.3e+00
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
cases:2.59%
controls:0.25%
—
0
7
318
3173
—
—
—
—
6
7
226
2748
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
7.5e-03
—
—
—
2.3e+00
6.7e-01
6.1e-02
cases:4.40%
controls:4.37%
—
—
—
—
—
—
cases:1.59%
controls:0.16%
cases:3.81%
controls:1.99%
cases:6.03%
controls:5.70%
14
139
304
3041
—
—
—
5
5
309
3174
11
62
278
3050
14
157
218
2598
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
2.3e+00
—
—
—
1.0e+50
1.0e+50
—
cases:2.52%
controls:0.25%
—
—
—
—
—
—
cases:4.14%
controls:0.00%
cases:3.81%
controls:0.00%
—
—
8
8
310
3172
—
—
—
13
0
301
3179
11
0
278
3112
—
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.16%
controls:0.22%
—
—
—
—
—
—
5
6
227
2749
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.16%
controls:0.22%
—
—
—
—
—
—
5
6
227
2749
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
—
1.6e+00
—
—
—
2.3e+00
5.2e-01
—
—
cases:1.89%
controls:0.38%
—
—
—
—
—
—
cases:3.11%
controls:0.32%
cases:2.59%
controls:1.56%
—
6
12
312
3168
—
—
—
9
10
280
3102
6
43
226
2712
Bacterial infection, unspecified
A49.9 [45590816]
1.3e+00
—
—
—
—
2.3e+00
1.1e+00
cases:2.83%
controls:0.82%
—
—
—
—
—
—
—
—
cases:2.77%
controls:0.29%
cases:4.31%
controls:1.42%
9
26
309
3154
—
—
—
—
8
9
281
3103
10
39
222
2716
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.3e+00
—
—
—
—
2.3e+00
1.1e+00
cases:3.14%
controls:0.88%
—
—
—
—
—
—
—
—
cases:4.50%
controls:0.48%
cases:4.31%
controls:1.42%
10
28
308
3152
—
—
—
—
13
15
276
3097
10
39
222
2716
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.7e-01
3.6e-01
6.6e-01
—
1.4e+00
9.0e-01
2.9e-01
cases:22.33%
controls:19.50%
cases:16.35%
controls:12.04%
cases:4.40%
controls:2.33%
—
—
cases:9.55%
controls:2.61%
cases:25.26%
controls:12.11%
cases:28.02%
controls:22.54%
71
620
247
2560
52
383
266
2797
14
74
304
3106
—
30
83
284
3096
73
377
216
2735
65
621
167
2134
Other oral or dental procedure
SXC05 [2001310586]
—
—
—
—
—
2.3e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.26%
cases:3.02%
controls:0.76%
—
—
—
—
—
7
8
282
3104
7
21
225
2734
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
3.3e-01
—
—
—
—
2.3e+00
7.1e-01
cases:3.46%
controls:2.52%
—
—
—
—
—
—
—
—
cases:7.96%
controls:0.90%
cases:5.60%
controls:2.83%
11
80
307
3100
—
—
—
—
23
28
266
3084
13
78
219
2677
Reparation of dental prosthesis without impressions
SPF00 [2001310544]
-1.0e+50
-1.0e+50
—
—
—
—
2.2e+00
cases:0.00%
controls:0.44%
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.33%
0
14
318
3166
0
5
318
3175
—
—
—
—
7
9
225
2746
Emergency Medicine
93 [38004510]
-1.7e-01
-4.3e-02
1.5e+00
—
6.5e-01
6.9e-01
-4.9e-02
cases:13.21%
controls:15.31%
cases:7.86%
controls:8.18%
cases:4.40%
controls:0.97%
—
—
cases:2.55%
controls:1.35%
cases:18.69%
controls:10.38%
cases:26.72%
controls:27.70%
42
487
276
2693
25
260
293
2920
14
31
304
3149
—
8
43
306
3136
54
323
235
2789
62
763
170
1992
Demanding periodontal treatment
SDA04 [2001310329]
-3.1e-01
—
—
—
2.2e+00
8.5e-01
2.4e-01
cases:3.77%
controls:5.06%
—
—
—
—
—
—
cases:2.55%
controls:0.28%
cases:4.84%
controls:2.12%
cases:9.48%
controls:7.59%
12
161
306
3019
—
—
—
8
9
306
3170
14
66
275
3046
22
209
210
2546
Metal-framed partial denture
SPE02 [2001310538]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.59%
controls:0.29%
—
—
—
—
—
—
6
8
226
2747
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
—
1.6e+00
—
—
—
2.2e+00
4.2e-01
—
—
cases:1.89%
controls:0.38%
—
—
—
—
—
—
cases:3.11%
controls:0.35%
cases:2.59%
controls:1.71%
—
6
12
312
3168
—
—
—
9
11
280
3101
6
47
226
2708
Hypothyroidism/myxoedema
T86 [2002001128]
—
-1.0e+50
—
—
—
-1.0e+50
2.2e+00
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:3.45%
controls:0.40%
—
0
6
318
3174
—
—
—
0
5
289
3107
8
11
224
2744
Flexible bronchoscopy
UGC12 [2001303610]
—
—
—
1.0e+50
—
1.0e+50
2.2e+00
—
—
—
—
—
—
cases:1.57%
controls:0.00%
—
—
cases:1.73%
controls:0.00%
cases:4.31%
controls:0.51%
—
—
—
5
0
313
3180
—
5
0
284
3112
10
14
222
2741
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
—
—
—
—
2.1e+00
7.3e-01
—
—
—
—
—
—
—
—
—
—
cases:5.88%
controls:0.74%
cases:6.90%
controls:3.45%
—
—
—
—
—
17
23
272
3089
16
95
216
2660
Gingivitis (chronic) NOS
K05.10 [2000502717]
1.1e-01
—
—
—
—
2.1e+00
5.4e-01
cases:1.57%
controls:1.42%
—
—
—
—
—
—
—
—
cases:5.88%
controls:0.74%
cases:3.88%
controls:2.29%
5
45
313
3135
—
—
—
—
17
23
272
3089
9
63
223
2692
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
—
—
—
—
—
2.1e+00
8.0e-01
—
—
—
—
—
—
—
—
—
—
cases:2.08%
controls:0.26%
cases:3.02%
controls:1.38%
—
—
—
—
—
6
8
283
3104
7
38
225
2717
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.1e-01
—
—
—
—
2.1e+00
7.7e-01
cases:1.57%
controls:1.42%
—
—
—
—
—
—
—
—
cases:5.88%
controls:0.77%
cases:6.90%
controls:3.30%
5
45
313
3135
—
—
—
—
17
24
272
3088
16
91
216
2664
Dental X-ray, bite-wing X-ray on one side of the mouth
EB1SA [2001301918]
-5.8e-01
2.0e-01
—
—
2.1e+00
8.2e-01
5.0e-01
cases:7.55%
controls:12.74%
cases:4.40%
controls:3.65%
—
—
—
—
cases:2.87%
controls:0.38%
cases:6.57%
controls:3.02%
cases:16.81%
controls:10.93%
24
405
294
2775
14
116
304
3064
—
—
9
12
305
3167
19
94
270
3018
39
301
193
2454
Respiratory and circulatory monitoring
WX700 [2001310817]
4.0e-01
—
—
—
—
2.0e+00
1.1e+00
cases:4.09%
controls:2.77%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.32%
cases:5.17%
controls:1.71%
13
88
305
3092
—
—
—
—
7
10
282
3102
12
47
220
2708
Addiction caused by alcohol UNS
F10.29 [2000501684]
2.0e+00
—
—
—
—
—
—
cases:1.89%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
312
3172
—
—
—
—
—
—
Examination of ears and hearing
Z01.1 [45547279]
9.1e-02
7.4e-01
—
—
—
2.0e+00
8.8e-01
cases:2.20%
controls:2.01%
cases:1.57%
controls:0.75%
—
—
—
—
—
—
cases:4.15%
controls:0.58%
cases:5.17%
controls:2.21%
7
64
311
3116
5
24
313
3156
—
—
—
12
18
277
3094
12
61
220
2694
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
1.6e+00
2.0e+00
1.0e+50
—
—
1.8e+00
—
cases:2.20%
controls:0.44%
cases:2.52%
controls:0.35%
cases:1.89%
controls:0.00%
—
—
—
—
cases:1.73%
controls:0.29%
—
—
7
14
311
3166
8
11
310
3169
6
0
312
3180
—
—
5
9
284
3103
—
Glucose [Moles/volume] in Venous blood
39480-9 [3038515]
1.6e+00
2.0e+00
1.0e+50
—
—
1.8e+00
—
cases:2.20%
controls:0.44%
cases:2.52%
controls:0.35%
cases:1.89%
controls:0.00%
—
—
—
—
cases:1.73%
controls:0.29%
—
—
7
14
311
3166
8
11
310
3169
6
0
312
3180
—
—
5
9
284
3103
—
Hematology
82 [38004501]
—
2.1e+00
—
—
—
2.0e+00
1.3e+00
—
—
cases:1.57%
controls:0.19%
—
—
—
—
—
—
cases:2.77%
controls:0.39%
cases:2.59%
controls:0.73%
—
5
6
313
3174
—
—
—
8
12
281
3100
6
20
226
2735
Depressive episode, unspecified
F32.9 [45571760]
1.1e+00
—
—
—
—
2.0e+00
—
cases:3.46%
controls:1.13%
—
—
—
—
—
—
—
—
cases:2.08%
controls:0.29%
—
—
11
36
307
3144
—
—
—
—
6
9
283
3103
—
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
2.1e-01
—
—
—
—
2.0e+00
3.2e-01
cases:2.83%
controls:2.30%
—
—
—
—
—
—
—
—
cases:6.57%
controls:0.96%
cases:4.31%
controls:3.16%
9
73
309
3107
—
—
—
—
19
30
270
3082
10
87
222
2668
Calcium.ionized [Moles/volume] in Venous blood
41645-3 [3033705]
2.0e+00
—
—
—
—
—
-1.0e+50
cases:2.20%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
7
10
311
3170
—
—
—
—
—
0
9
232
2746
Potassium [Moles/volume] in Venous blood
39789-3 [3041354]
2.0e+00
—
—
—
—
—
-1.0e+50
cases:2.20%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
7
10
311
3170
—
—
—
—
—
0
9
232
2746
Chloride [Moles/volume] in Venous blood
41649-5 [3035285]
2.0e+00
—
—
—
—
—
-1.0e+50
cases:2.20%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
7
10
311
3170
—
—
—
—
—
0
9
232
2746
Speech therapy
R4130 [2001310235]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.44%
—
—
—
—
—
—
7
12
225
2743
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
0.0e+00
3.5e-02
—
—
1.2e+00
7.3e-01
2.3e-01
cases:16.35%
controls:16.35%
cases:9.12%
controls:8.84%
—
—
—
—
cases:3.82%
controls:1.16%
cases:15.57%
controls:8.16%
cases:26.72%
controls:22.40%
52
520
266
2660
29
281
289
2899
—
—
12
37
302
3142
45
254
244
2858
62
617
170
2138
Gastroenterology
10 [38004455]
1.1e-02
2.3e-01
—
—
1.9e+00
9.2e-01
5.9e-01
cases:5.97%
controls:5.91%
cases:2.83%
controls:2.26%
—
—
—
—
cases:2.55%
controls:0.38%
cases:5.54%
controls:2.28%
cases:11.21%
controls:6.53%
19
188
299
2992
9
72
309
3108
—
—
8
12
306
3167
16
71
273
3041
26
180
206
2575
Periodontal treatment, brief
SDA02 [2001310327]
-5.7e-02
-5.0e-01
—
—
—
1.2e+00
6.9e-01
cases:7.55%
controls:7.96%
cases:1.89%
controls:3.08%
—
—
—
—
—
—
cases:8.30%
controls:2.57%
cases:14.66%
controls:7.95%
24
253
294
2927
6
98
312
3082
—
—
—
24
80
265
3032
34
219
198
2536
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
-2.4e-01
—
—
—
—
1.9e+00
7.7e-01
cases:1.57%
controls:1.98%
—
—
—
—
—
—
—
—
cases:6.92%
controls:1.09%
cases:9.48%
controls:4.61%
5
63
313
3117
—
—
—
—
20
34
269
3078
22
127
210
2628
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
2.2e-01
4.2e-01
—
—
1.9e+00
5.9e-01
3.4e-01
cases:8.49%
controls:6.92%
cases:5.66%
controls:3.81%
—
—
—
—
cases:3.18%
controls:0.50%
cases:7.27%
controls:4.18%
cases:21.55%
controls:16.37%
27
220
291
2960
18
121
300
3059
—
—
10
16
304
3163
21
130
268
2982
50
451
182
2304
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
2.2e-01
1.9e+00
—
—
—
5.6e-01
2.1e-01
cases:3.77%
controls:3.05%
cases:6.92%
controls:1.13%
—
—
—
—
—
—
cases:1.73%
controls:1.00%
cases:3.02%
controls:2.47%
12
97
306
3083
22
36
296
3144
—
—
—
5
31
284
3081
7
68
225
2687
Gas panel - Venous blood
24339-4 [3000991]
1.3e+00
—
—
—
—
1.9e+00
8.1e-01
cases:2.52%
controls:0.72%
—
—
—
—
—
—
—
—
cases:3.81%
controls:0.61%
cases:7.76%
controls:3.59%
8
23
310
3157
—
—
—
—
11
19
278
3093
18
99
214
2656
Right side
ZXA00 [2001311346]
3.1e-01
—
—
1.0e+50
—
1.9e+00
8.0e-01
cases:5.35%
controls:3.99%
—
—
—
—
cases:2.83%
controls:0.00%
—
—
cases:4.15%
controls:0.67%
cases:5.17%
controls:2.40%
17
127
301
3053
—
—
9
0
309
3180
—
12
21
277
3091
12
66
220
2689
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
6.6e-01
—
—
—
1.7e+00
1.8e+00
1.4e+00
cases:1.57%
controls:0.82%
—
—
—
—
—
—
cases:1.59%
controls:0.28%
cases:4.50%
controls:0.74%
cases:3.88%
controls:1.02%
5
26
313
3154
—
—
—
5
9
309
3170
13
23
276
3089
9
28
223
2727
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
4.4e-01
—
—
—
—
1.8e+00
7.6e-01
cases:2.52%
controls:1.64%
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.80%
cases:6.03%
controls:2.90%
8
52
310
3128
—
—
—
—
14
25
275
3087
14
80
218
2675
Urgent procedure
ZXD05 [2001311386]
-2.2e-01
—
—
—
—
1.8e+00
9.6e-01
cases:3.77%
controls:4.65%
—
—
—
—
—
—
—
—
cases:3.81%
controls:0.64%
cases:6.03%
controls:2.40%
12
148
306
3032
—
—
—
—
11
20
278
3092
14
66
218
2689
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
8.5e-01
9.3e-01
-1.0e+50
—
—
1.8e+00
6.8e-01
cases:4.09%
controls:1.79%
cases:1.57%
controls:0.63%
cases:0.00%
controls:0.16%
—
—
—
—
cases:4.15%
controls:0.71%
cases:5.17%
controls:2.69%
13
57
305
3123
5
20
313
3160
0
5
318
3175
—
—
12
22
277
3090
12
74
220
2681
Left side
ZXA05 [2001311347]
4.1e-02
6.6e-01
—
—
—
1.8e+00
8.4e-01
cases:4.09%
controls:3.93%
cases:1.57%
controls:0.82%
—
—
—
—
—
—
cases:4.84%
controls:0.84%
cases:4.74%
controls:2.11%
13
125
305
3055
5
26
313
3154
—
—
—
14
26
275
3086
11
58
221
2697
macrogol; oral
A06AD15 [21600575]
3.6e-01
—
—
—
—
1.8e+00
2.7e-01
cases:1.89%
controls:1.32%
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.84%
cases:3.02%
controls:2.32%
6
42
312
3138
—
—
—
—
14
26
275
3086
7
64
225
2691
Retained dental root
K08.3 [45543292]
5.5e-01
—
—
—
1.0e+50
1.8e+00
7.0e-01
cases:1.89%
controls:1.10%
—
—
—
—
—
—
cases:2.55%
controls:0.00%
cases:2.77%
controls:0.48%
cases:2.59%
controls:1.31%
6
35
312
3145
—
—
—
8
0
306
3179
8
15
281
3097
6
36
226
2719
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
6.0e-02
—
—
—
-1.0e+50
1.8e+00
4.3e-01
cases:2.20%
controls:2.08%
—
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:3.46%
controls:0.61%
cases:4.74%
controls:3.12%
7
66
311
3114
—
—
—
0
7
314
3172
10
19
279
3093
11
86
221
2669
allopurinol; oral, parenteral
M04AA01 [21604131]
1.6e-01
3.3e-01
—
—
1.8e+00
2.4e-01
3.6e-01
cases:3.77%
controls:3.24%
cases:2.83%
controls:2.04%
—
—
—
—
cases:3.18%
controls:0.57%
cases:3.46%
controls:2.73%
cases:5.17%
controls:3.67%
12
103
306
3077
9
65
309
3115
—
—
10
18
304
3161
10
85
279
3027
12
101
220
2654
Stomatognathic treatment, basic
SHA02 [2001310406]
-1.0e+50
—
—
—
—
—
1.7e+00
cases:0.00%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.54%
0
17
318
3163
—
—
—
—
—
7
15
225
2740
Lutropin [Units/volume] in Serum or Plasma
10501-5 [3009214]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.54%
—
—
—
—
—
—
7
15
225
2740
Fungus identified in Specimen by Culture
580-1 [3000494]
7.5e-01
—
—
—
—
1.7e+00
6.3e-01
cases:4.72%
controls:2.30%
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.90%
cases:6.47%
controls:3.56%
15
73
303
3107
—
—
—
—
14
28
275
3084
15
98
217
2657
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
1.8e-01
1.2e+00
—
—
—
1.7e+00
—
cases:1.57%
controls:1.32%
cases:2.20%
controls:0.66%
—
—
—
—
—
—
cases:2.77%
controls:0.51%
—
—
5
42
313
3138
7
21
311
3159
—
—
—
8
16
281
3096
—
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.7e+00
—
—
—
—
—
1.4e+00
cases:2.52%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:3.02%
controls:0.80%
8
15
310
3165
—
—
—
—
—
7
22
225
2733
pH of Serum or Plasma
2753-2 [3018418]
3.5e-01
3.1e-01
—
—
—
1.7e+00
5.8e-01
cases:8.49%
controls:6.16%
cases:4.40%
controls:3.27%
—
—
—
—
—
—
cases:15.57%
controls:3.31%
cases:16.81%
controls:10.16%
27
196
291
2984
14
104
304
3076
—
—
—
45
103
244
3009
39
280
193
2475
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
1.8e-01
4.3e-01
1.7e+00
—
1.2e+00
6.3e-01
7.0e-02
cases:6.92%
controls:5.85%
cases:7.86%
controls:5.25%
cases:3.77%
controls:0.72%
—
—
cases:2.87%
controls:0.88%
cases:11.76%
controls:6.62%
cases:23.71%
controls:22.47%
22
186
296
2994
25
167
293
3013
12
23
306
3157
—
9
28
305
3151
34
206
255
2906
55
619
177
2136
clindamycin; oral, parenteral
J01FF01 [21602985]
-8.0e-02
—
—
—
—
1.7e+00
5.8e-01
cases:3.14%
controls:3.40%
—
—
—
—
—
—
—
—
cases:4.15%
controls:0.80%
cases:5.17%
controls:2.98%
10
108
308
3072
—
—
—
—
12
25
277
3087
12
82
220
2673
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
1.8e-01
5.5e-01
—
—
—
1.7e+00
1.9e-01
cases:1.57%
controls:1.32%
cases:1.57%
controls:0.91%
—
—
—
—
—
—
cases:3.46%
controls:0.67%
cases:3.02%
controls:2.50%
5
42
313
3138
5
29
313
3151
—
—
—
10
21
279
3091
7
69
225
2686
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
1.5e+00
1.6e+00
—
—
—
1.5e+00
—
cases:2.52%
controls:0.60%
cases:2.52%
controls:0.50%
—
—
—
—
—
—
cases:2.08%
controls:0.48%
—
—
8
19
310
3161
8
16
310
3164
—
—
—
6
15
283
3097
—
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
1.3e+00
1.6e+00
1.0e+50
—
—
1.4e+00
—
cases:2.52%
controls:0.69%
cases:2.52%
controls:0.50%
cases:1.89%
controls:0.00%
—
—
—
—
cases:2.08%
controls:0.51%
—
—
8
22
310
3158
8
16
310
3164
6
0
312
3180
—
—
6
16
283
3096
—
Streptococcus pyogenes Ag [Presence] in Throat
18481-2 [3033319]
2.3e-01
1.6e+00
—
—
—
-1.0e+50
4.2e-01
cases:1.89%
controls:1.51%
cases:2.52%
controls:0.50%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:2.59%
controls:1.71%
6
48
312
3132
8
16
310
3164
—
—
—
0
6
289
3106
6
47
226
2708
valaciclovir; oral
J05AB11 [21603137]
7.0e-02
7.0e-01
—
—
—
1.6e+00
3.2e-01
cases:1.89%
controls:1.76%
cases:1.57%
controls:0.79%
—
—
—
—
—
—
cases:3.46%
controls:0.71%
cases:2.59%
controls:1.89%
6
56
312
3124
5
25
313
3155
—
—
—
10
22
279
3090
6
52
226
2703
enoxaparin; parenteral
B01AB05 [21600976]
3.0e-01
4.5e-01
—
—
—
1.6e+00
6.6e-01
cases:6.29%
controls:4.75%
cases:2.20%
controls:1.42%
—
—
—
—
—
—
cases:5.88%
controls:1.25%
cases:7.33%
controls:3.92%
20
151
298
3029
7
45
311
3135
—
—
—
17
39
272
3073
17
108
215
2647
clindamycin; vaginal
G01AA10 [21602372]
5.9e-01
—
—
—
—
—
1.6e+00
cases:1.57%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.83%
5
28
313
3152
—
—
—
—
—
9
23
223
2732
Periodontal treatment
SDA03 [2001310328]
-8.6e-02
2.4e-01
—
—
—
1.6e+00
3.3e-01
cases:7.23%
controls:7.83%
cases:3.77%
controls:2.99%
—
—
—
—
—
—
cases:14.88%
controls:3.53%
cases:15.52%
controls:11.62%
23
249
295
2931
12
95
306
3085
—
—
—
43
110
246
3002
36
320
196
2435
One-surface restoration
SFA10 [2001310358]
-3.7e-01
-9.6e-02
—
—
1.2e+00
7.9e-01
7.7e-01
cases:12.58%
controls:17.30%
cases:5.66%
controls:6.19%
—
—
—
—
cases:3.18%
controls:0.98%
cases:12.46%
controls:6.07%
cases:32.76%
controls:18.40%
40
550
278
2630
18
197
300
2983
—
—
10
31
304
3148
36
189
253
2923
76
507
156
2248
Psychiatry
26 [38004469]
6.2e-01
-1.9e-01
—
—
—
1.5e+00
4.0e-01
cases:7.55%
controls:4.21%
cases:1.57%
controls:1.89%
—
—
—
—
—
—
cases:7.27%
controls:1.67%
cases:5.60%
controls:3.81%
24
134
294
3046
5
60
313
3120
—
—
—
21
52
268
3060
13
105
219
2650
Body CT examination
JN4AD [2001310897]
—
—
—
—
—
2.2e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.19%
cases:5.60%
controls:1.31%
—
—
—
—
—
5
6
284
3106
13
36
219
2719
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-4.0e-01
-3.4e-01
—
—
1.5e+00
5.6e-01
-3.9e-01
cases:5.03%
controls:7.30%
cases:2.52%
controls:3.49%
—
—
—
—
cases:2.87%
controls:0.66%
cases:5.88%
controls:3.44%
cases:6.47%
controls:9.29%
16
232
302
2948
8
111
310
3069
—
—
9
21
305
3158
17
107
272
3005
15
256
217
2499
Caries of cementum
K02.2 [45591568]
1.1e+00
—
—
—
—
—
1.5e+00
cases:1.57%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.91%
5
17
313
3163
—
—
—
—
—
9
25
223
2730
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
8.1e-01
—
—
—
1.0e+50
1.2e+00
1.4e+00
cases:3.46%
controls:1.57%
—
—
—
—
—
—
cases:2.23%
controls:0.00%
cases:3.11%
controls:0.93%
cases:9.48%
controls:2.47%
11
50
307
3130
—
—
—
7
0
307
3179
9
29
280
3083
22
68
210
2687
aciclovir; oral, parenteral
J05AB01 [21603131]
2.1e-01
5.2e-01
—
—
—
1.4e+00
4.7e-01
cases:2.83%
controls:2.30%
cases:1.57%
controls:0.94%
—
—
—
—
—
—
cases:3.46%
controls:0.87%
cases:3.45%
controls:2.18%
9
73
309
3107
5
30
313
3150
—
—
—
10
27
279
3085
8
60
224
2695
oxazepam; oral
N05BA04 [21604569]
2.6e-01
3.2e-01
—
—
1.3e+00
1.4e+00
6.1e-01
cases:5.97%
controls:4.65%
cases:3.14%
controls:2.30%
—
—
—
—
cases:2.55%
controls:0.69%
cases:8.65%
controls:2.28%
cases:9.91%
controls:5.63%
19
148
299
3032
10
73
308
3107
—
—
8
22
306
3157
25
71
264
3041
23
155
209
2600
prednisolone; oral, parenteral
H02AB06 [21602734]
5.2e-02
-1.8e-01
—
—
1.4e+00
5.4e-01
3.9e-01
cases:12.58%
controls:12.01%
cases:4.72%
controls:5.60%
—
—
—
—
cases:3.50%
controls:0.91%
cases:8.65%
controls:5.21%
cases:16.38%
controls:11.72%
40
382
278
2798
15
178
303
3002
—
—
11
29
303
3150
25
162
264
2950
38
323
194
2432
prednisolone
A07EA01 [21600653]
5.0e-02
-1.8e-01
—
—
1.4e+00
5.3e-01
3.8e-01
cases:12.58%
controls:12.04%
cases:4.72%
controls:5.60%
—
—
—
—
cases:3.50%
controls:0.91%
cases:8.65%
controls:5.27%
cases:16.38%
controls:11.80%
40
383
278
2797
15
178
303
3002
—
—
11
29
303
3150
25
164
264
2948
38
325
194
2430
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-1.9e-01
1.4e-01
3.9e-01
—
1.4e+00
4.4e-01
1.5e-01
cases:16.04%
controls:18.77%
cases:11.32%
controls:10.00%
cases:1.57%
controls:1.07%
—
—
cases:4.78%
controls:1.26%
cases:13.84%
controls:9.42%
cases:28.88%
controls:25.88%
51
597
267
2583
36
318
282
2862
5
34
313
3146
—
15
40
299
3139
40
293
249
2819
67
713
165
2042
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
7.1e-01
3.2e-01
—
—
—
1.3e+00
2.5e-01
cases:4.09%
controls:2.04%
cases:2.20%
controls:1.60%
—
—
—
—
—
—
cases:6.57%
controls:1.80%
cases:8.62%
controls:6.86%
13
65
305
3115
7
51
311
3129
—
—
—
19
56
270
3056
20
189
212
2566
Pneumonia, unspecified
J18.9 [45601123]
2.2e-01
—
—
—
2.1e+00
1.3e+00
7.5e-01
cases:4.09%
controls:3.30%
—
—
—
—
—
—
cases:1.59%
controls:0.19%
cases:4.15%
controls:1.16%
cases:8.62%
controls:4.28%
13
105
305
3075
—
—
—
5
6
309
3173
12
36
277
3076
20
118
212
2637
Pulmonary Disease
29 [38004472]
-3.4e-02
2.5e-01
1.3e+00
—
8.7e-01
6.2e-01
3.5e-01
cases:11.32%
controls:11.67%
cases:7.55%
controls:5.97%
cases:3.77%
controls:1.10%
—
—
cases:2.23%
controls:0.94%
cases:9.69%
controls:5.46%
cases:17.67%
controls:13.10%
36
371
282
2809
24
190
294
2990
12
35
306
3145
—
7
30
307
3149
28
170
261
2942
41
361
191
2394
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
8.0e-01
6.2e-01
—
—
—
1.3e+00
4.6e-01
cases:5.03%
controls:2.33%
cases:2.83%
controls:1.54%
—
—
—
—
—
—
cases:6.23%
controls:1.86%
cases:9.05%
controls:5.92%
16
74
302
3106
9
49
309
3131
—
—
—
18
58
271
3054
21
163
211
2592
Hypothyroidism, unspecified
E03.9 [45537945]
4.0e-01
—
—
—
—
1.1e+00
1.2e+00
cases:2.52%
controls:1.70%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.80%
cases:7.76%
controls:2.36%
8
54
310
3126
—
—
—
—
7
25
282
3087
18
65
214
2690
combinations of corticosteroids
D07XB30 [21602188]
2.9e-02
3.0e-01
—
—
1.3e+00
1.2e+00
4.2e-01
cases:12.58%
controls:12.26%
cases:5.97%
controls:4.50%
—
—
—
—
cases:1.59%
controls:0.44%
cases:12.11%
controls:3.82%
cases:18.10%
controls:12.67%
40
390
278
2790
19
143
299
3037
—
—
5
14
309
3165
35
119
254
2993
42
349
190
2406
combinations of corticosteroids
D07AB30 [21602118]
2.9e-02
3.0e-01
—
—
1.3e+00
1.2e+00
4.2e-01
cases:12.58%
controls:12.26%
cases:5.97%
controls:4.50%
—
—
—
—
cases:1.59%
controls:0.44%
cases:12.11%
controls:3.82%
cases:18.10%
controls:12.67%
40
390
278
2790
19
143
299
3037
—
—
5
14
309
3165
35
119
254
2993
42
349
190
2406
Telehealth
OMOP5556618 [722455]
-6.0e-02
3.5e-01
1.2e+00
—
6.2e-01
3.7e-01
3.5e-01
cases:29.25%
controls:30.50%
cases:15.09%
controls:11.16%
cases:5.35%
controls:1.60%
—
—
cases:4.14%
controls:2.26%
cases:14.53%
controls:10.51%
cases:23.28%
controls:17.64%
93
970
225
2210
48
355
270
2825
17
51
301
3129
—
13
72
301
3107
42
327
247
2785
54
486
178
2269
Essential (primary) hypertension
I10 [45591453]
-2.8e-02
-7.5e-02
1.0e+00
—
1.2e+00
2.5e-01
-1.3e-01
cases:21.38%
controls:21.86%
cases:10.38%
controls:11.10%
cases:4.09%
controls:1.51%
—
—
cases:5.41%
controls:1.64%
cases:14.53%
controls:11.66%
cases:28.45%
controls:31.18%
68
695
250
2485
33
353
285
2827
13
48
305
3132
—
17
52
297
3127
42
363
247
2749
66
859
166
1896
Atrial fibrillation and flutter
I48 [45596206]
-1.2e-01
6.1e-02
1.2e+00
1.0e+50
7.8e-01
4.4e-01
-2.7e-01
cases:7.23%
controls:8.08%
cases:4.40%
controls:4.15%
cases:3.77%
controls:1.13%
cases:1.89%
controls:0.00%
cases:1.91%
controls:0.88%
cases:5.88%
controls:3.86%
cases:6.03%
controls:7.77%
23
257
295
2923
14
132
304
3048
12
36
306
3144
6
0
312
3180
6
28
308
3151
17
120
272
2992
14
214
218
2541
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
4.7e-02
1.6e-01
5.3e-02
—
3.9e-01
2.5e-01
1.2e+00
cases:8.18%
controls:7.83%
cases:9.12%
controls:7.86%
cases:3.14%
controls:2.99%
—
—
cases:3.18%
controls:2.17%
cases:10.38%
controls:8.29%
cases:25.00%
controls:9.40%
26
249
292
2931
29
250
289
2930
10
95
308
3085
—
10
69
304
3110
30
258
259
2854
58
259
174
2496
zopiclone; oral
N05CF01 [21604654]
4.4e-01
4.7e-01
1.1e+00
—
6.5e-01
1.1e+00
6.1e-01
cases:11.32%
controls:7.58%
cases:6.92%
controls:4.43%
cases:2.83%
controls:0.97%
—
—
cases:2.55%
controls:1.35%
cases:12.46%
controls:4.53%
cases:12.93%
controls:7.48%
36
241
282
2939
22
141
296
3039
9
31
309
3149
—
8
43
306
3136
36
141
253
2971
30
206
202
2549
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.7e-01
-8.8e-02
1.5e+00
—
1.9e+00
1.1e+00
3.2e-01
cases:8.18%
controls:5.28%
cases:2.83%
controls:3.08%
cases:1.57%
controls:0.35%
—
—
cases:1.59%
controls:0.25%
cases:8.65%
controls:3.15%
cases:12.07%
controls:9.04%
26
168
292
3012
9
98
309
3082
5
11
313
3169
—
5
8
309
3171
25
98
264
3014
28
249
204
2506

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
151
72
38.61
214.84
1.6
1.3
—
—
—
0
0
220
755
7.04
65.01
3.3
1.6
—
—
—
0
0
91
211
5.62
39.03
1.4
1.1
—
—
—
0
0
186
833
3.92
32.40
7.0
2.0
2.38
2.35
mmol/l
1.62
177
722
175
790
3.66
29.34
3.3
2.1
—
—
—
0
0
252
1454
4.37
28.77
14.6
6.1
4.05
4.29
e9/l
0.89
224
1256
213
1123
3.65
27.32
3.7
2.4
—
—
estimate
—
0
0
236
1369
3.71
25.15
10.5
4.2
10.96
12.72
umol/l
1.36
230
1299
210
1176
3.26
22.82
7.3
3.9
34.79
35.74
g/l
1.48
201
1097
150
744
2.90
19.37
5.4
3.8
—
—
—
0
0
52
144
4.11
17.14
4.0
1.5
4.61
2.60
ug/l
1.36
47
101
146
766
2.66
16.23
4.2
3.3
7.41
7.40
ph
1.08
103
542
195
1190
2.62
15.68
9.1
6.1
1.20
1.21
mmol/l
0.11
188
1080
210
1334
2.65
15.44
10.4
6.5
1.21
1.21
mmol/l
0.08
185
1152
153
852
2.52
14.65
7.7
5.4
—
—
—
0
0
129
672
2.53
14.14
1.6
1.3
—
—
—
0
0
195
1236
2.46
13.77
7.8
5.6
0.60
0.70
%
1.86
183
1151
194
1229
2.46
13.68
7.9
5.6
2.70
3.15
%
1.54
182
1146
193
1227
2.43
13.40
7.9
5.7
9.30
9.04
%
0.61
183
1143
43
125
3.82
13.15
1.2
1.2
144.19
112.68
u/ml
0.14
13
52
205
1353
2.42
12.87
7.4
5.5
0.61
0.61
e9/l
0.09
170
1150
79
337
2.78
12.82
1.9
1.7
—
—
—
0
0
205
1362
2.39
12.55
7.4
5.5
0.04
0.04
e9/l
1.63
168
1163
70
284
2.87
12.45
2.7
2.2
9.91
7.72
umol/l
0.29
61
255
203
1347
2.37
12.40
13.4
15.1
1.18
1.31
inr
3.41
159
1115
193
1257
2.34
12.26
7.9
5.6
21.80
26.79
%
7.71
185
1188
21
18
12.39
12.00
1.4
1.2
24.35
28.26
ng/l
0.39
21
18
204
1375
2.32
11.75
7.4
5.6
1.73
1.83
e9/l
0.11
171
1208
15
5
31.34
11.75
1.1
1.0
—
—
—
0
0
206
1400
2.31
11.55
7.5
5.6
0.18
0.22
e9/l
2.06
173
1218
188
1242
2.23
11.13
7.7
5.6
61.90
57.75
%
4.48
181
1180
133
784
2.19
10.26
10.3
4.3
—
—
—
0
0
15
9
17.39
9.97
4.1
2.1
0.61
0.59
mmol/l
—
15
9
75
350
2.49
9.95
12.2
8.1
1.76
1.18
mmol/l
0.48
65
293
75
360
2.41
9.32
12.3
8.0
5.27
5.14
kpa
0.73
70
350
96
526
2.18
8.66
6.6
2.1
2.52
2.44
mmol/l
5.03
89
455
73
360
2.33
8.47
12.6
8.0
7.40
7.41
ph
0.38
24
201
58
258
2.52
8.44
14.1
8.8
—
—
—
0
0
74
371
2.29
8.25
1.9
1.5
—
—
—
0
0
171
1175
1.97
8.17
16.5
9.9
0.00
0.00
e9/l
0.39
128
962
81
430
2.18
7.83
2.5
2.9
1.04
1.72
e6/l
0.68
44
204
66
325
2.30
7.64
13.4
8.3
95.91
94.82
%
0.44
66
318
51
227
2.48
7.38
3.9
2.0
63.75
40.01
u/l
0.66
44
181
116
750
1.85
6.24
2.6
2.9
0.27
0.43
e6/l
0.81
87
542
76
428
2.02
6.17
2.3
2.0
—
—
—
0
0
130
875
1.81
6.12
2.9
3.0
32.89
130.15
e6/l
0.70
99
668
108
687
1.86
6.10
2.5
2.8
—
0.00
estimate
—
0
7
240
1962
1.88
5.67
6.2
3.7
14.49
14.89
pmol/l
1.64
235
1784
137
980
1.69
4.96
3.5
3.6
202.50
131.77
e6/l
0.18
103
696
10
13
7.90
4.88
1.3
1.0
—
—
—
0
0
292
2606
2.29
4.67
30.8
14.1
27.84
24.86
mg/l
1.06
278
2096
78
494
1.76
4.29
2.9
2.7
549.46
543.69
mosm/kgh2o
0.08
65
428
11
22
5.14
4.04
1.3
1.3
—
—
—
0
0
7
9
7.92
3.57
1.7
1.6
2.90
5.11
nmol/l
—
7
9
274
2446
1.81
3.55
7.1
4.7
3.16
1.97
mu/l
2.98
265
2222
10
23
4.45
3.33
1.4
1.4
—
—
—
0
0
12
33
3.74
3.32
2.2
2.2
4.26
4.71
e9/l
0.24
12
33
17
66
2.66
3.27
2.8
3.9
3.30
1.28
index
—
10
32
7
11
6.48
3.20
1.6
1.0
—
—
—
0
0
9
20
4.60
3.13
1.2
1.4
—
—
—
0
0
9
20
4.60
3.13
1.0
1.2
—
—
—
0
0
13
45
2.97
3.06
2.2
2.0
66.23
60.90
%
0.72
13
45
212
1815
1.49
2.89
3.7
3.4
77.03
52.45
u/l
0.80
199
1715
7
13
5.48
2.88
1.1
1.5
—
—
—
0
0
82
1106
0.65
2.80
2.9
3.5
52.58
51.19
mg/l
0.02
57
744
6
10
6.09
2.71
3.0
1.7
163.50
231.50
e6/l
—
6
10
20
93
2.23
2.67
1.8
2.0
21.30
20.52
s
0.71
20
84
36
210
1.80
2.60
4.8
3.9
0.93
0.33
%
1.19
14
45
52
337
1.65
2.59
2.1
1.9
1.93
1.75
%
0.59
46
301
82
593
1.51
2.56
5.0
4.2
276.68
525.39
ng/l
0.44
72
495
41
250
1.73
2.55
1.3
1.4
—
—
—
0
0
86
1131
0.67
2.53
3.1
3.4
9.16
8.31
mmol/l
0.64
75
971
114
885
1.45
2.49
3.8
2.4
49.58
63.14
u/l
1.58
109
825
28
153
1.91
2.47
1.2
1.6
—
—
—
0
0
243
2648
0.66
2.45
6.0
7.2
38.74
40.25
mmol/mol
2.43
224
2492
92
689
1.47
2.41
2.5
2.2
3.39
2.76
mg/l
0.63
78
586
43
648
0.61
2.36
3.9
3.8
1.02
1.02
kg/l
1.22
31
426
87
1128
0.69
2.33
3.7
4.2
5.43
8.01
mg/mmol
0.55
55
742
6
13
4.68
2.28
3.3
4.8
0.83
1.08
index
—
6
13
6
14
4.35
2.16
3.2
1.8
646.50
1263.50
e6/l
—
6
14
99
1238
0.71
2.10
1.9
2.0
1.39
1.36
mmol/l
0.11
80
1040
46
306
1.59
2.08
1.3
1.7
—
—
—
0
0
5
10
5.06
2.08
3.2
1.3
62.60
195.70
e6/l
—
5
10
6
15
4.05
2.05
1.0
1.1
—
—
—
0
0
6
15
4.05
2.05
1.5
1.1
—
—
—
0
0
29
172
1.75
2.01
3.3
2.6
1.43
1.18
%
0.51
29
172
78
588
1.43
1.95
1.8
1.7
2.17
1.20
mg/l
1.14
62
465
38
246
1.62
1.92
1.2
1.6
—
—
—
0
0
28
168
1.73
1.88
3.4
2.6
0.64
0.62
%
0.20
28
168
85
1073
0.72
1.86
4.0
3.5
0.00
0.02
estimate
0.78
28
227
48
332
1.52
1.84
4.5
3.5
7.40
7.39
ph
0.41
21
206
79
603
1.41
1.84
2.2
2.3
6.43
4.53
e6/l
0.35
70
546
35
225
1.62
1.83
5.5
4.0
1.08
0.64
%
0.67
13
52
116
946
1.35
1.81
2.4
2.3
320.64
294.03
u/l
0.05
111
891
34
218
1.63
1.79
5.5
4.1
0.08
0.07
%
0.07
12
45
254
2711
0.70
1.76
4.7
5.7
4.55
4.47
mmol/l
0.47
239
2540
9
36
2.54
1.75
5.1
2.6
1.20
1.19
mmol/l
—
9
36
36
528
0.64
1.74
1.2
1.3
0.83
1.37
u/ml
—
8
162
253
2696
0.71
1.65
4.5
5.6
1.43
1.39
mmol/l
0.86
236
2503
53
389
1.43
1.53
1.2
1.2
—
—
—
0
0
5
15
3.37
1.53
3.0
1.9
0.30
0.79
e9/l
—
5
15
9
37
2.47
1.49
5.1
2.6
4.01
4.13
mmol/l
—
9
37
9
37
2.47
1.49
5.1
2.6
106.33
105.84
mmol/l
—
9
37
85
680
1.34
1.47
3.0
3.0
—
—
—
0
0
72
562
1.36
1.46
4.0
4.2
—
—
—
0
0
291
2769
1.53
1.45
34.9
18.0
138.84
139.81
mmol/l
8.69
291
2714
243
2593
0.74
1.44
4.1
4.7
1.34
1.32
mmol/l
0.09
227
2388
12
60
2.04
1.40
1.2
1.1
—
—
—
0
0
37
260
1.48
1.35
2.2
1.9
74.25
67.97
e9/l
0.42
25
198
31
210
1.53
1.34
5.7
3.2
119.13
131.00
g/l
1.80
31
205
6
24
2.53
1.31
2.5
2.2
—
—
—
0
0
22
138
1.64
1.30
9.1
5.3
1.06
0.86
%
1.10
22
133
32
221
1.50
1.27
5.8
4.3
0.10
0.00
%
—
10
34
134
1165
1.26
1.21
2.1
2.4
76.37
76.26
nmol/l
0.01
122
1031
32
444
0.69
1.19
1.2
1.3
1.24
13.11
u/ml
3.72
13
178
36
484
0.71
1.12
1.1
1.3
16.73
39.48
iu/ml
2.83
12
150
10
181
0.54
1.12
1.2
1.3
227.81
357.74
u/ml
—
10
168
95
1112
0.79
1.10
3.2
3.3
6.38
6.19
ph
0.67
50
645
7
32
2.21
1.08
1.1
1.4
—
—
—
0
0
7
32
2.21
1.08
1.1
1.4
—
—
—
0
0
7
32
2.21
1.08
1.1
1.4
—
—
—
0
0
7
32
2.21
1.08
1.1
1.4
—
—
—
0
0
12
67
1.82
1.06
1.4
1.3
289.83
300.91
ug/g
—
6
39
7
34
2.08
1.03
4.9
1.8
2.49
111.95
u/ml
—
7
34
5
109
0.45
1.02
1.2
1.1
—
1.21
—
0
9
126
1420
0.81
1.01
3.8
3.6
0.00
0.02
estimate
0.65
30
251
25
175
1.46
0.96
5.3
5.4
—
—
—
0
0
86
1003
0.81
0.95
3.3
3.2
1882.05
1393.31
ng/l
0.24
76
841
11
63
1.77
0.91
1.4
1.1
—
—
—
0
0
5
103
0.48
0.91
3.2
11.6
—
—
—
0
0
265
2757
0.78
0.89
5.2
6.5
2.64
2.61
mmol/l
0.12
244
2569
94
1080
0.82
0.89
3.6
3.6
—
—
—
0
0
24
170
1.44
0.88
1.1
1.3
—
—
—
0
0
8
45
1.80
0.85
1.0
1.0
—
—
—
0
0
126
1402
0.83
0.84
3.6
3.6
54.34
0.00
estimate
0.49
35
274
15
97
1.57
0.83
4.0
3.1
27.61
25.40
mmol/l
0.85
15
97
12
73
1.67
0.82
6.0
3.0
7.41
7.41
ph
0.03
12
73
10
163
0.60
0.81
1.6
1.9
41.30
40.21
nmol/l
—
10
154
6
33
1.83
0.79
1.0
1.3
29.67
33.39
pg
—
6
33
65
767
0.81
0.79
3.5
3.6
0.00
0.01
estimate
0.50
27
246
6
34
1.78
0.76
2.3
3.4
—
—
—
0
0
67
785
0.82
0.76
3.0
2.4
319.77
369.04
umol/l
3.43
61
695
98
861
1.20
0.76
1.8
1.7
19.60
19.93
nmol/l
0.07
86
724
31
237
1.34
0.76
3.6
3.9
7.32
7.34
ph
0.13
25
161
129
1169
1.17
0.69
2.7
2.8
160.40
146.55
ug/l
0.27
120
1087
7
42
1.68
0.69
8.0
3.0
9.34
8.54
kpa
—
7
42
7
42
1.68
0.69
8.0
3.0
4.93
4.94
kpa
—
7
42
7
43
1.64
0.67
1.3
1.2
—
—
—
0
0
5
28
1.80
0.66
1.4
1.4
14.20
17.17
%
—
5
28
5
29
1.74
0.64
1.0
1.2
—
—
—
0
0
8
49
1.65
0.62
6.6
2.8
—
—
—
0
0
127
1384
0.86
0.61
3.7
3.6
0.00
0.00
estimate
-0.00
34
269
0
21
0.00
0.60
0.0
1.5
—
236.86
—
0
14
8
52
1.55
0.60
1.0
1.1
—
—
—
0
0
13
90
1.46
0.56
1.8
2.8
374.00
245.11
mg/l
—
8
36
17
125
1.38
0.55
1.4
1.7
—
—
—
0
0
292
2853
1.25
0.52
37.6
19.0
79.51
83.49
umol/l
1.78
292
2814
40
472
0.83
0.50
1.6
1.3
2.24
2.88
g/l
1.25
22
292
13
93
1.41
0.49
1.4
1.5
—
12.53
—
0
21
146
1557
0.89
0.48
4.4
4.1
2.30
1.83
ug/l
1.02
133
1406
281
2741
1.20
0.47
23.8
12.8
—
—
—
0
0
12
163
0.73
0.45
1.3
1.4
—
32.43
—
0
13
5
31
1.62
0.43
1.2
1.6
13.22
11.21
%
—
5
31
5
31
1.62
0.43
1.0
1.6
8.08
8.11
mmol/l
—
5
31
5
32
1.57
0.42
1.4
1.0
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
23.48
—
0
16
18
141
1.29
0.41
1.8
2.5
—
—
—
0
0
7
105
0.66
0.40
1.3
1.8
—
—
—
0
0
68
752
0.88
0.40
3.3
3.0
0.00
0.00
estimate
-0.00
24
214
13
170
0.75
0.39
1.2
1.2
—
—
—
0
0
8
114
0.69
0.38
5.0
4.4
27.10
25.18
mmol/l
—
8
104
11
81
1.37
0.36
1.2
1.7
—
—
—
0
0
22
181
1.23
0.35
3.3
3.0
—
—
—
0
0
14
109
1.30
0.34
1.0
1.2
—
—
—
0
0
53
589
0.88
0.34
1.7
1.8
447.91
31910997.02
pmol/l
0.69
46
492
230
2233
1.11
0.32
34.6
18.3
331.89
333.49
g/l
1.79
230
2222
21
250
0.83
0.31
2.8
1.9
0.00
0.06
estimate
—
8
52
10
75
1.34
0.30
6.3
4.3
—
—
—
0
0
33
375
0.87
0.29
1.3
1.3
546.67
482.45
titre
—
6
98
10
128
0.77
0.27
3.9
2.0
0.00
6.12
estimate
—
5
41
17
142
1.21
0.25
4.2
3.5
1.02
1.02
ratio
0.44
17
134
11
87
1.27
0.24
1.8
1.2
0.98
0.89
g/l
0.64
11
87
17
143
1.20
0.23
1.5
1.6
0.36
0.39
mg/l
—
10
74
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
15.3
—
1050.00
—
0
11
0
12
0.00
0.21
0.0
3.8
—
23.64
—
0
12
0
13
0.00
0.21
0.0
1.0
—
1693.15
—
0
13
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
6
48
1.25
0.20
4.8
2.6
5.97
10.92
pmol/l
—
6
48
0
14
0.00
0.20
0.0
1.1
—
5.83
—
0
9
6
50
1.20
0.20
2.3
3.0
—
—
—
0
0
7
58
1.21
0.18
1.3
1.1
56.71
13.38
u/l
—
7
50
123
1188
1.06
0.16
5.2
4.0
458.53
75.34
ng/l
0.43
104
887
292
2893
1.10
0.15
41.9
21.3
92.12
91.42
fl
1.65
292
2857
9
82
1.10
0.15
2.9
1.2
25.92
33.54
mg/l
—
9
72
9
82
1.10
0.15
2.9
1.2
43.19
47.12
mg/l
—
9
71
292
2894
1.10
0.14
41.8
21.3
30.66
30.54
pg
0.48
292
2858
292
2894
1.10
0.14
43.8
21.9
38.60
41.21
%
11.17
292
2857
52
490
1.07
0.14
1.9
1.7
949.92
1179.64
nmol/l
1.45
39
380
292
2895
1.09
0.14
42.3
21.5
128.92
139.00
g/l
17.42
292
2861
21
232
0.90
0.13
1.9
3.6
252.67
209.91
ng/l
0.12
21
215
94
907
1.05
0.13
2.8
2.8
0.74
0.70
ug/l
0.27
68
561
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
11
97
1.14
0.09
1.5
1.8
—
—
—
0
0
6
54
1.11
0.09
1.0
1.4
—
—
—
0
0
13
144
0.90
0.08
1.1
1.1
—
—
—
0
0
27
287
0.94
0.08
1.5
1.5
—
—
—
0
0
7
64
1.10
0.08
2.9
2.8
0.86
0.87
nmol/l
—
7
53
22
205
1.08
0.08
4.5
3.8
5.54
5.24
kpa
0.75
22
198
8
74
1.08
0.07
1.1
1.2
—
—
—
0
0
8
93
0.86
0.07
2.8
1.7
—
—
—
0
0
17
161
1.06
0.03
1.4
1.3
—
—
—
0
0
15
142
1.06
0.02
4.1
4.1
—
—
—
0
0
267
2660
1.02
0.02
4.5
5.5
5.96
6.10
mmol/l
1.22
254
2439
16
167
0.96
0.01
2.4
1.4
—
—
—
0
0
19
191
0.99
0.00
2.0
2.0
3.71
3.46
mmol/l
0.54
19
151
135
1346
1.01
0.00
2.2
2.1
89.31
95.75
pmol/l
0.96
79
695
12
117
1.03
0.00
1.3
1.3
—
—
—
0
0
12
116
1.04
0.00
1.1
1.3
—
—
—
0
0
34
335
1.02
0.00
4.4
2.5
3.42
4.31
e9/l
1.57
28
285
27
274
0.98
0.00
1.3
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
7.0
—
8.26
—
0
8
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.2
1.3
0.56
38.41
nmol/l
—
5
45
8
84
0.95
-0.00
1.8
1.2
1.56
1.47
g/l
—
8
84
0
6
0.00
-0.00
0.0
1.5
—
16.92
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
44.57
—
0
7
0
7
0.00
-0.00
0.0
12.9
—
0.72
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.9
—
6.51
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
74.29
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BASEOFTONGUE_WIDE – Malignant neoplasm of base of tongue, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).